In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant: Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd., Inventia Healthcare LLC, ScieGen Pharmaceuticals Inc., Bactolac Pharmaceutical Inc., Laurus Labs Limited, Laurus Generics Inc., Alkem Laboratories Ltd. and S&B Pharma, Inc.
Counter Defendant: Merck Sharp & Dohme Corp.
Not Classified By Court: Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited, Zydus Pharmaceuticals (USA) Inc., Sun Pharma Global FZE, Alvogen Pine Brook LLC, Wockhardt USA LLC, Par Pharmaceuticals, Inc., Clerk of MDL Panel, Lupin Pharmaceuticals, Inc., Apotex Corp., Macleods Pharma USA, Inc., Wockhardt Bio AG, Lupin Limited, Watson Laboratories, Inc., Alvogen Malta Operations Ltd., Cadila Healthcare Ltd., Anchen Pharmaceuticals, Inc., Sandoz Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharmaceuticals Inc., Alvogen Pine Brook, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., Unichem Laboratories Limited, Unichem Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC
Counter Claimant: Macleods Pharmaceuticals Limited
In Re: In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Case Number: 1:2019md02902
Filed: August 8, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on March 1, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 1, 2022 Pro Hac Vice Attorney Jonathan B. Turpin for Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(mal)
February 25, 2022 Filing 659 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Joyce, Alexandra)
February 24, 2022 Pro Hac Vice Attorney Timothy F. Peterson for Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(mal)
February 23, 2022 Filing 658 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Second Set of Interrogatories to Plaintiff (No. 3) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Second Set of Requests for Admission to Plaintiff (Nos. 7-15) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
February 23, 2022 Pro Hac Vice Attorney Leah M. Brackensick for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
February 22, 2022 Filing 657 MOTION for Pro Hac Vice Appearance of Attorney Jonathan B. Turpin, Timothy F. Peterson and Lean M. Brackensick - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: #1 Certification of Jonathan B. Turpin, #2 Certification of Timothy F. Peterson, #3 Certification of Leah M. Brackensick)(Bilson, David)
February 22, 2022 Filing 656 NOTICE OF SERVICE of (1) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Requests for Admission to Plaintiff (Nos. 1-6) and (2) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Interrogatories (Nos. 1-2) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 22, 2022 Opinion or Order SO ORDERED, re (657 in 19-md-2902-RGA; 44 in 21-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jonathan B. Turpin, Timothy F. Peterson and Lean M. Brackensick, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. Signed by Judge Richard G. Andrews on 2/22/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms)
February 18, 2022 Filing 655 NOTICE OF SERVICE of (1) Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., (2) Third Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., and (3) Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
February 11, 2022 Filing 654 NOTICE requesting Clerk to remove Christopher J. Cassella as co-counsel. Reason for request: No Longer with Firm. (Bilson, David)
February 10, 2022 Filing 653 CONSENT JUDGMENT between Annora Pharma Private Limited, Hetero USA Inc., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/10/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms)
February 9, 2022 Filing 652 PROPOSED Consent Judgment between Plaintiff and Annora Pharma Private Limited, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 2/10/2022 (nms).
February 1, 2022 Filing 651 NOTICE OF SERVICE of (1) First Set of Requests for Admission from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., and (2) Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
January 28, 2022 Filing 650 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
January 21, 2022 Filing 649 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Interrogatories to Plaintiff (Nos. 1-2) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Requests for Admission to Plaintiff (Nos. 1-6) filed by Zydus Worldwide DMCC.(Bilson, David)
January 7, 2022 Filing 648 CONSENT JUDGMENT between Plaintiff and MSN Laboratories Private Limited, and MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 1/7/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms)
January 7, 2022 Filing 647 PROPOSED Consent Judgment as to Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 1/7/2022 (nms).
December 29, 2021 Filing 646 NOTICE of SERVICE of Hetero's Paragraph 3 Initial Disclosures by Hetero USA Inc., (Capuzzi, Kevin)
December 29, 2021 Filing 645 NOTICE of SERVICE of Annora's Paragraph 3 Initial Disclosures by Annora Pharma Private Limited (Capuzzi, Kevin)
December 23, 2021 Filing 644 NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Annora Pharma Private Limited and Hetero USA Inc.; and (3) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Annora Pharma Private Limited and Hetero USA Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
December 20, 2021 Filing 643 Joint Status Report and Stipulation to Extend Time, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/20/2021 (nms). Modified on 12/20/2021 (nms).
December 20, 2021 Opinion or Order SO ORDERED Granting (D.I. 12 in 21-cv-1172-RGA; D.I. 643 in 19-md-2902-RGA) Joint Status Report and Stipulation to Extend Time to January 20, 2022. Signed by Judge Richard G. Andrews on 12/20/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms)
December 15, 2021 Opinion or Order Filing 642 ORAL ORDER: Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited answers were due to be filed on 12/13/2021, and to date none have been filed. Plaintiff is now requested to file a status letter within 3 days from the entry of this Order. Ordered by Judge Richard G. Andrews on 12/15/2021. Associated Cases: 1:21-cv-01172-RGA, 1:19-md-02902-RGA(nms)
December 10, 2021 Filing 641 CONSENT JUDGMENT between Merck Sharp & Dohme Corp., Alkem Laboratories Ltd., and S&B Pharma, Inc.. Signed by Judge Richard G. Andrews on 12/10/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
December 9, 2021 Filing 640 PROPOSED Consent Judgment between Plaintiff and Defendants Alkem Laboratories Ltd. and S&B Pharma, Inc., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/9/2021 (nms).
December 7, 2021 Filing 639 CONSENT JUDGMENT between Merck Sharp & Dohme Corp., Laurus Labs Limited and Laurus Generics Inc.. Signed by Judge Richard G. Andrews on 12/7/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01173-RGA(nms)
December 7, 2021 Filing 638 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/7/2021 (nms).
December 6, 2021 Filing 637 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to December 13, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
December 6, 2021 Filing 636 NOTICE of Defendant Hetero USA Inc.'s Initial Disclosures Pursuant to FRCP Rule 26(a)(1) by Hetero USA Inc., (Capuzzi, Kevin)
December 6, 2021 Filing 635 NOTICE of SERVICE of Defendant Annora Pharma Private Ltd.'s Initial Disclosures Pursuant to FRCP Rule 26(a)(1), by Annora Pharma Private Limited. (Capuzzi, Kevin) Modified on 12/6/2021 (nms).
December 6, 2021 Opinion or Order SO ORDERED, re (D.I. 637 in 19-md-2902-RGA; D.I. 6 in 21-cv-824-RGA) STIPULATION and Proposed Order to Extend Time to Answer, Move, or Otherwise Respond to the Complaint to December 13, 2021. Signed by Judge Richard G. Andrews on 12/6/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
December 3, 2021 Filing 634 NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
December 1, 2021 CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-01006-RGA, 1:19-md-02902-RGA(Taylor, Daniel)
November 30, 2021 Opinion or Order SO ORDERED, re (D.I. 633 in 19-md-2902-RGA; D.I. 15 in 21-cv-824-RGA) STIPULATION TO EXTEND TIME the Deadline for Alkem to Answer, Move, or Otherwise Respond to the Complaint to December 6, 2021. Signed by Judge Richard G. Andrews on 11/30/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
November 29, 2021 Filing 633 STIPULATION TO EXTEND TIME the Deadline for Alkem to Answer, Move, or Otherwise Respond to the Complaint to December 6, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 29, 2021 Opinion or Order Filing 632 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 4/22/2022. Amended Pleadings due by 4/22/2022. Fact Discovery completed by 7/15/2022. A Pretrial Conference is set for 5/12/2023, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 6/5/2023, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 11/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms)
November 24, 2021 Filing 631 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 11/24/2021 (nms).
November 23, 2021 Opinion or Order Filing 630 SO ORDERED Granting #629 Consent Judgment (*Bactolac Pharmaceutical Inc. and ScieGen Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 11/23/2021. (nms)
November 23, 2021 Filing 629 PROPOSED Consent Judgment as to Defendants ScieGen Pharmaceuticals, Inc. and Bactolac Pharmaceutical Inc., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2021 (nms).
November 23, 2021 Filing 628 Joint Status Report and Stipulation to Extend Time, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2021 (nms).
November 23, 2021 Opinion or Order SO ORDERED Granting (D.I. 10 in 21-cv-1172-RGA; D.I. 628 in 19-md-2902-RGA) Stipulation to Extend Time to answer, move or otherwise respond to the complaint to December 13,2021. Signed by Judge Richard G. Andrews on 11/23/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01172-RGA(nms)
November 1, 2021 Filing 627 NOTICE requesting Clerk to remove Jingyuan Luo as co-counsel.. (Silver, Daniel)
October 26, 2021 Filing 626 STIPULATION TO EXTEND TIME the Deadline for Alkem to Answer, Move, or Otherwise Respond to the Complaint to November 29, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
October 26, 2021 Opinion or Order SO ORDERED, re (D.I. 14 in 21-cv-824-RGA; D.I. 626 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time for Alkem to Answer, Move, or Otherwise Respond to the Complaint to November 29, 2021. Signed by Judge Richard G. Andrews on 10/26/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
October 5, 2021 Filing 625 CONSENT JUDGMENT between Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 10/5/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA, 1:21-cv-01033-RGA(nms)
October 4, 2021 Filing 624 PROPOSED Consent Judgment between Plaintiff and to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 10/5/2021 (nms).
October 1, 2021 Opinion or Order Filing 623 ORAL ORDER: The request to cancel the bench trial set to start October, 4, 2021 (D.I. 116 in 20-cv-847-RGA; D.I. 622 in 19-md-2902-RGA) is GRANTED. Ordered by Judge Richard G. Andrews on 10/1/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
October 1, 2021 Filing 622 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Requesting Cancellation Of October 4, 2021 Bench Trial. (Silver, Daniel)
October 1, 2021 Filing 621 REDACTED VERSION of #618 Amended Document, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 10/1/2021 (nms).
October 1, 2021 Filing 620 REDACTED VERSION of #602 Exhibit to a Document, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 10/1/2021 (nms).
October 1, 2021 Opinion or Order SO ORDERED, re (D.I. 113 in 20-cv-847-RGA; D.I. 619 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME for Defendants' to submit their Pretrial Brief to 6:00 a.m. on October 1, 2021. Signed by Judge Richard G. Andrews on 10/1/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
September 30, 2021 Filing 619 STIPULATION TO EXTEND TIME for Defendants' to submit their Pretrial Brief to 6:00 a.m. on October 1, 2021 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (O'Byrne, Stephanie)
September 30, 2021 Filing 618 [SEALED] AMENDED Exhibit 4P to Proposed Pretrial Order, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 10/1/2021 (nms).
September 30, 2021 Filing 617 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s First Set of Interrogatories (Nos. 1-7) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s First Set of Requests for Production (Nos. 1-73) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
September 30, 2021 Filing 616 CONSENT JUDGMENT between Merck Sharp & Dohme Corp. and Sun Pharmaceutical Industries Ltd.. Signed by Judge Richard G. Andrews on 9/30/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00319-RGA(nms)
September 30, 2021 Filing 615 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/30/2021 (nms).
September 30, 2021 Filing 614 CONSENT JUDGMENT between Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/30/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 30, 2021 Remark: The Bench Trial scheduled to start 10/4/2021, will now be held in Courtroom 6A. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00319-RGA, 1:20-cv-00847-RGA(lak)
September 30, 2021 Remark: The public may access the bench trial scheduled to begin on 10/4/2021 at 8:30 a.m., by dialing the following phone number: 1-703-552-8058, then enter conference number: 231224. The dial-in information provides listening capabilities only. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(lak)
September 29, 2021 Filing 613 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/30/2021 (nms).
September 29, 2021 Opinion or Order Filing 612 SO ORDERED Granting (D.I. 125 in 20-cv-949-RGA; D.I. 204 in 19-cv-319-RGA; D.I. 611 in 19-md-2902-RGA; D.I. 110 in 20-cv-847-RGA: D.I. 130 in 20-cv-1099-RGA) Stipulation and Proposed Order Regarding COVID-19 Protocols. Signed by Judge Richard G. Andrews on 9/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00319-RGA, 1:20-cv-00847-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 29, 2021 Filing 611 STIPULATION and [Proposed] Order Regarding COVID-19 Protocols by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) (Main Document 611 replaced on 9/29/2021) (nms).
September 29, 2021 Filing 610 STIPULATION and [Proposed] Order to Extend Time to Respond to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
September 29, 2021 Filing 609 CONSENT JUDGMENT between Apotex Corp., Apotex Inc., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00313-RGA, 1:20-cv-00749-RGA(nms)
September 29, 2021 Opinion or Order SO ORDERED, re (D.I. 610 in 19-md-2902-RGA; D.I. 13 in 21-cv-824-RGA) Stipulation and Proposed Order to Extend Time to Respond to Complaint to October 29, 2021. Signed by Judge Richard G. Andrews on 9/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
September 29, 2021 CORRECTING ENTRY: The pdf for the Stipulation and Proposed Order Regarding COVID-19 Protocols filed on 9/29/2021, has been replaced with an amended version. The case caption has been updated. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA, 1:20-cv-00847-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 28, 2021 Filing 608 REDACTED VERSION of #605 Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/29/2021 (nms).
September 28, 2021 Filing 607 REDACTED VERSION of #604 Stipulation of Dismissal, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/29/2021 (nms).
September 28, 2021 Filing 606 PROPOSED Consent Judgment as to Defendants Apotex Inc. and Apotex Corp., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/29/2021 (nms).
September 28, 2021 Opinion or Order Filing 605 [SEALED] ORDER Granting (D.I. 174 in 19-cv-314-RGA; 604 in 19-md-2902-RGA) Stipulation and Proposed Order of Dismissal. Signed by Judge Richard G. Andrews on 9/28/2021.This order has been emailed to local counsel. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00314-RGA(nms)
September 28, 2021 CORRECTING ENTRY: The pdfs for D.I. 604 in 19md2902-RGA, and D.I. 174 in 19cv314-RGA, have been replaced with amended versions per the parties request. Associated Cases: 1:19-cv-00314-RGA, 1:19-md-02902-RGA(nms)
September 27, 2021 Filing 604 [SEALED] STIPULATION of Dismissal Without Prejudice as to Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/28/2021 (nms). (Main Document 604 replaced on 9/28/2021) (nms).
September 27, 2021 Filing 603 CONSENT JUDGMENT between Merck Sharp & Dohme Corp. and Sandoz Inc.. Signed by Judge Richard G. Andrews on 9/27/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00312-RGA(nms)
September 24, 2021 Filing 602 [SEALED] Amended Exhibit to Proposed Pretrial Order, by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel) Modified on 9/27/2021 (nms).
September 24, 2021 Filing 601 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/27/2021 (nms).
September 24, 2021 Opinion or Order Filing 600 SO ORDERED Granting (D.I. 193 in 19-cv-313-RGA; D.I. 183 in 19-cv-312-RGA; D.I. 599 in 19-md-2902-RGA; D.I. 107 in 20-cv-847-RGA; D.I. 201 in 19-cv-319-RGA; D.I. 171 in 19-cv-314-RGA; D.I. 127 in 20-cv-1099-RGA; D.I. 122 in 20-cv-949-RGA; D.I. 129 in 20-cv-749-RGA) Stipulation and Proposed Order Regarding Pretrial Briefing. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 24, 2021 Filing 599 STIPULATION and [Proposed] Order Regarding Pretrial Briefing by Merck Sharp & Dohme Corp.. (Silver, Daniel)
September 24, 2021 Opinion or Order Filing 598 SO ORDERED Granting (D.I. 597 in 19-md-2902-RGA; D.I. 191 in 19-cv-313-RGA; D.I. 181 in 19-cv-312-RGA; D.I. 199 in 19-cv-319-RGA; D.I. 120 in 20-cv-949-RGA: D.I. 105 in 20-cv-847-RGA; D.I. 127 in 20-cv-749-RGA; D.I. 125 in 20-cv-1099-RGA; D.I. 169 in 19-cv-314-RGA) Stipulation and Proposed Order Narrowing Disputes for Trial. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 24, 2021 Filing 597 STIPULATION and [Proposed] Order Narrowing Disputes for Trial by Merck Sharp & Dohme Corp.. (Silver, Daniel)
September 24, 2021 Filing 596 NOTICE OF SERVICE of Plaintiff's Responses and Objections To Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Requests for the Production of Documents and Things (Nos. 1-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
September 24, 2021 Opinion or Order Filing 595 ORDER: Merck's request regarding obviousness-type double patenting (D.I. #586 ) is DENIED. Signed by Judge Richard G. Andrews on 9/24/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 23, 2021 Filing 594 REDACTED VERSION of #586 Letter, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/24/2021 (nms).
September 23, 2021 Opinion or Order Filing 593 SO ORDERED Granting Stipulation and Proposed Order (see D.I. 120 in 20-cv-749-RGA; D.I. 588 in 19-md-2902-RGA; D.I. 118 in 20-cv-1099-RGA; D.I. 191 in 19-cv-319-RGA; D.I. 184 in 19-cv-313-RGA; D.I. 174 in 19-cv-312-RGA; D.I. 162 in 19-cv-314-RGA; D.I. 113 in 20-cv-949-RGA; D.I. 97 in 20-cv-847-RGA). Signed by Judge Richard G. Andrews on 9/23/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 23, 2021 Filing 592 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding the Court's September 22, 2021. (Silver, Daniel) Modified on 9/23/2021 (nms).
September 22, 2021 Filing 591 Joint Letter to The Honorable Richard G. Andrews, from David E. Moore, regarding Obvious-Type Double Patenting. (Moore, David) Modified on 9/23/2021 (nms).
September 22, 2021 Filing 590 REDACTED VERSION of #569 Proposed Pretrial Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/23/2021 (nms).
September 22, 2021 Opinion or Order Filing 589 ORAL ORDER: A join letter addressing whether paragraph 3 of the Stipulation (see D.I. 588 in 19md2902-RGA) is referencing anybody besides Dr. Buckton is due no later than 48 hour from the date of this Order. Ordered by Judge Richard G. Andrews on 9/22/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 22, 2021 Remark: The Bench Trial scheduled to start 10/4/2021, will now be held in Courtroom 4B. Associated Cases: 1:19-md-02902-RGA et al.(lak) Modified on 9/23/2021 (nms).
September 21, 2021 Filing 588 STIPULATION and [Proposed] Order Regarding Trial Vendor for Remote Testimony and Viewing of Validity Bench Trial, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/21/2021 (nms).
September 20, 2021 Opinion or Order SO ORDERED, re (D.I. 119 in 20-cv-749-RGA; D.I. 112 in 20-cv-949-RGA: D.I. 183 in 19-cv-313-RGA; D.I. 173 in 19-cv-312-RGA; D.I. 190 in 19-cv-319-RGA; D.I. 587 in 19-md-2902-RGA; D.I. 96 in 20-cv-847-RGA; D.I. 161 in 19-cv-314-RGA; D.I. 117 in 20-cv-1099-RGA) STIPULATION TO EXTEND TIME to submit a public redacted version of the Proposed Joint Pretrial Order for Validity Trial to September 22, 2021. Signed by Judge Richard G. Andrews on 9/20/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 17, 2021 Filing 587 STIPULATION TO EXTEND TIME to submit a public redacted version of the Proposed Joint Pretrial Order for Validity Trial to September 22, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/20/2021 (nms).
September 16, 2021 Filing 586 [SEALED] Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding obvious-type double patenting estoppel for upcoming validity trial. (Attachments: #1 Exhibit 1, #2 Certificate of Service)(Silver, Daniel) Modified on 9/17/2021 (nms).
September 15, 2021 Filing 585 CONSENT JUDGMENT between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01496-RGA(nms)
September 15, 2021 Filing 584 CONSENT JUDGMENT between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00815-RGA(nms)
September 15, 2021 Filing 583 PROPOSED Consent Judgment as to Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/15/2021 (nms).
September 15, 2021 Filing 582 PROPOSED Consent Judgment as to Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/15/2021 (nms).
September 15, 2021 Filing 581 APPOINTMENT of Commissioners Under the Hague Convention and Request for Judicial Assistance. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 15, 2021 Opinion or Order Filing 580 SO ORDERED Granting (D.I. 113 in 20-cv-1099-RGA; D.I. 108 in 20-cv-949-RGA; 579 in D.I. 19-md-2902-RGA) Stipulation and Proposed Order for Entry of Letter of Request for Judicial Assistance to Facilitate Remote Trial Testimony of Dr. Fabia Gozzo in Switzerland. Signed by Judge Richard G. Andrews on 9/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 15, 2021 Filing 579 STIPULATION and Proposed Order for Entry of Letter of Request for Judicial Assistance to Facilitate Remote Trial Testimony of Dr. Fabia Gozzo in Switzerland, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A)(Silver, Daniel) Modified on 9/15/2021 (nms).
September 15, 2021 Filing 578 Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding request to supplement Exhibits 5D(a) through 5D(c) of the Pretrial Order with copies of Defendants' experts' curricula vitae. (Attachments: #1 Exhibit 5D(a), #2 Exhibit 5D(b), #3 Exhibit 5D(c))(Gattuso, Dominick) Modified on 9/15/2021 (nms).
September 13, 2021 Filing 577 NOTICE OF SERVICE of Reply Expert Report of David MacMillan, Ph.D. Regarding Apotex's Infringement of the U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
September 10, 2021 Opinion or Order Filing 576 ORDER AFTER PRETRIAL CONFERENCE (see Order for further details). Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-md-02902-RGA et al.(nms)
September 10, 2021 Filing 575 STIPULATION and Proposed Order to Extend Time to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 9/10/2021 (nms).
September 10, 2021 Minute Entry for proceedings held before Judge Richard G. Andrews - Pretrial Conference held on 9/10/2021. Counsel for Plaintiff: D. Silver, A. Joyce. Counsel for Defendants: A. Gaza, J. Phillips, E. Ormerod, D. Gattuso. A 3 day Bench Trial is set to begin on 10/4/2021 in Courtroom 6A. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al. (lak)
September 10, 2021 Opinion or Order SO ORDERED, re (D.I. 179 in 19-cv-313-RGA; D.I. 50 in 20-cv-1496-RGA: D.I. 111 in 20-cv-1099-RGA: D.I. 575 in 19-md-2902-RGA; D.I. 158 in 19-cv-314-RGA: 115 in 20-cv-749-RGA: 75 in 20-cv-815-RGA; D.I. 187 in 19-cv-319-RGA: D.I. 93 in 20-cv-847-RGA: D.I. 169 in 19-cv-312-RGA; D.I. 106 in 20-cv-949-RGA) STIPULATION TO EXTEND TIME the Deadline to Submit a Redacted Version of the Proposed Joint Pretrial Order to September 17, 2021. Signed by Judge Richard G. Andrews on 9/10/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms)
September 9, 2021 Pro Hac Vice Attorney Kendall K. Gurule for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
September 9, 2021 Opinion or Order SO ORDERED, re (D.I. 574 in 19-md-2902-RGA; D.I. 9 in 21-cv-1006-RGA) STIPULATION TO EXTEND TIME the Deadline to Answer, Move or Otherwise Respond to the Complaint to October 11, 2021. Signed by Judge Richard G. Andrews on 9/9/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms)
September 9, 2021 Remark: The public may access the hearing scheduled for 9/10/2021, at 8:15 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 258126659#. The dial-in information provides listening capabilities only. Associated Cases: 1:19-md-02902-RGA et al. (lak)
September 8, 2021 Filing 574 STIPULATION TO EXTEND TIME the Deadline to Answer, Move or Otherwise Respond to the Complaint to October 11, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
September 8, 2021 Opinion or Order Filing 573 ORAL ORDER: The Pretrial Conference set for 9/10/2021 will now begin at 8:15 AM and will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 12:00 PM on 9/9/2021. Ordered by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-md-02902-RGA et al.(lak)
September 8, 2021 Filing 572 MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for David M. Krinsky)(Silver, Daniel)
September 8, 2021 Opinion or Order SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms)
September 7, 2021 Filing 571 MOTION for Pro Hac Vice Appearance of Attorney Kendall K. Gurule of Lerner, David, Littenberh, Krumholz & Mentlik LLP - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (O'Byrne, Stephanie)
September 7, 2021 Filing 570 NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. 282 [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick)
September 7, 2021 Opinion or Order SO ORDERED, re (D.I. 571 in 19-md-2902-RGA; D.I. 90 in 20-cv-847-RGA) MOTION for Pro Hac Vice Appearance of Attorney Kendall K. Gurule of Lerner, David, Littenberh, Krumholz & Mentlik LLP, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 9/7/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
September 3, 2021 Filing 569 [SEALED] Joint Proposed Pretrial Order for Validity Trial, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits 1-7)(Joyce, Alexandra) Modified on 9/6/2021 (nms).
August 30, 2021 Filing 568 STIPULATION Designating Record on Remand by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
August 27, 2021 Filing 567 STIPULATION and Proposed Order to Extend Time to Respond to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
August 27, 2021 Opinion or Order SO ORDERED, re (D.I. 567 in 19-md-2902-RGA; D.I. 11 in 21-cv-824-RGA) Stipulation and Proposed Order to Extend Time to Respond to Complaint to September 29, 2021. Signed by Judge Richard G. Andrews on 8/27/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
August 26, 2021 Filing 566 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Requests for Production to Plaintiff (Nos. 1-13) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
August 25, 2021 Opinion or Order SO ORDERED, re (D.I. 565 in 19-md-2902-RGA; 111 in 20-cv-749-RGA) Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 8/25/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
August 24, 2021 Filing 565 STIPULATION To Extend Time to Serve Reply Expert Reports (459 Patent) and Close of Expert Discovery (459) Patent by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
August 23, 2021 Opinion or Order Filing 564 STATMENT: Regarding impasse on "Statement of Contested Issues of Fact" for inclusion in the proposed pretrial order (see Statement for further details). Signed by Judge Richard G. Andrews on 8/23/2021. (nms)
August 23, 2021 Filing 563 CONDITIONAL REMAND ORDER. Signed by John W. Nichols Clerk of the Panel on 8/20/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms) (Main Document 563 replaced on 8/23/2021) (nms).
August 19, 2021 Filing 562 Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., responding to Merck's Letter. (Gattuso, Dominick) Modified on 8/21/2021 (nms).
August 19, 2021 Filing 561 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding the Submission of the Pretrial Order. (Silver, Daniel)
August 17, 2021 Filing 560 NOTICE OF SERVICE of (1) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. and (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceutical (USA) Inc. and Cadila Healthcare Ltd. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
August 16, 2021 Filing 559 CONSENT JUDGMENT between Merck Sharp & Dohme Corp. and Inventia Healthcare LLC, Inventia Healthcare Ltd.. Signed by Judge Richard G. Andrews on 8/16/2021. (nms)
August 12, 2021 Filing 558 PROPOSED Consent Judgment between Plaintiff and Defendants Inventia Healthcare Limited and Inventia Healthcare LLC, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/13/2021 (nms).
August 11, 2021 Pro Hac Vice Attorney Vanessa O. Omoroghomwan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
August 10, 2021 Filing 557 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
August 6, 2021 Opinion or Order Filing 556 SUGGSTION OF REMAND ORDER (see D.I. 204 in 19-cv-1489-RGA; D.I. 555 in 19-md-2902-RGA Stipulation and Proposed Order Regarding Remand of Mylan Matter to Northern District of West Virginia. Signed by Judge Richard G. Andrews on 8/6/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms)
August 6, 2021 Filing 555 STIPULATION regarding remand of Mylan matter to the Northern District of West Virginia re (203 in 1:19-cv-01489-RGA, 554 in 1:19-md-02902-RGA) Letter by Mylan Pharmaceuticals Inc.. (Hitch, Cortlan)
August 6, 2021 Filing 554 Letter to The Honorable Richard G. Andrews from Cortlan S. Hitch regarding transfer of Mylan matter back to West Virginia. (Hitch, Cortlan)
August 5, 2021 Filing 553 NOTICE of Appearance by Julie M. O'Dell on behalf of Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (O'Dell, Julie)
August 4, 2021 Filing 552 DECLARATION of Service on Dr. Reddy's Laboratories, Ltd., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 8/4/2021 (nms).
August 4, 2021 Filing 551 DECLARATION of Service on Dr. Reddy's Laboratories, Inc., by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 8/4/2021 (nms).
August 2, 2021 Filing 550 NOTICE to Take Deposition of Joseph H. Reibenspies, Ph.D. on August 13, 20210 at 9:00 am ET filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
August 2, 2021 Filing 549 NOTICE to Take Deposition of Ralph Tarantino, R.Ph., Ph.D. on August 9, 2021 at 9:00 am ET filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
August 2, 2021 Filing 548 NOTICE OF SERVICE of [CONFIDENTIAL] Reply Expert Report of John Hartwig, Ph.D. Regarding U.S. Patent No. 7,468,459 filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
July 29, 2021 Filing 547 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding transferring the Mylan matter. (Silver, Daniel) Modified on 7/30/2021 (nms).
July 29, 2021 Filing 546 NOTICE to Take Deposition of Dr. G. Patrick Stahly on August 3, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 29, 2021 Filing 545 NOTICE to Take Deposition of Stephen R. Little on August 6, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 29, 2021 Filing 544 NOTICE to Take Deposition of Dr. Fabia Gozzo on August 30, 2021 at 3:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 29, 2021 Filing 543 NOTICE to Take Deposition of Allan S. Myerson on August 11, 2021 at 9:00 a.m. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 26, 2021 Filing 542 NOTICE OF SERVICE of Supplemental Reply Report of Steven R. Little, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 8,414,921 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 23, 2021 Filing 541 NOTICE to Take Deposition of William E. Mayo, Ph.D. on August 11, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 22, 2021 Filing 540 NOTICE to Take Deposition of Alan Myerson on July 28, 2021 (Notice to Take Virtual Deposition) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
July 22, 2021 Filing 539 NOTICE to Take Deposition of Zachary Bloomgarden, M.D. filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
July 21, 2021 Filing 538 STIPULATION and [Proposed] Order to Amend Case Schedule by Apotex Corp., Apotex Inc., Apotex Inc.. (Bilson, David)
July 21, 2021 Opinion or Order SO ORDERED, re (D.I. 106 in 20-cv-749-RGA 538 in 19-md-2902-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 7/21/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
July 20, 2021 Filing 537 NOTICE to Take Deposition of Leonard J. Chyall, Ph. D. on July 23, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 19, 2021 Filing 536 NOTICE OF SERVICE of (1) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding DRL's Infringement of U.S. Patent No. 7,326,708 and (2) Reply Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of DRL Samples filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
July 19, 2021 Filing 535 NOTICE to Take Deposition of David MacMillan on July 21, 2021 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
July 15, 2021 Filing 534 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to August 16, 2021 - filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. (Poff, Adam)
July 15, 2021 Opinion or Order SO ORDERED, re (12 in 21-cv-182-RGA; 534 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to August 16, 2021. Signed by Judge Richard G. Andrews on 7/15/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00182-RGA(nms)
July 12, 2021 Filing 533 NOTICE of Remote Deposition of Jennifer Swift, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel)
July 12, 2021 Filing 532 NOTICE of Remote Deposition of Graham Buckton, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel)
July 9, 2021 Filing 531 NOTICE OF SERVICE of Responses and Objections to the Second Set of Requests for Production and the Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 8, 2021 Filing 530 NOTICE of Deposition of Allan Myerson, by Mylan Pharmaceuticals Inc.. (Hitch, Cortlan) Modified on 7/9/2021 (nms).
July 8, 2021 CORRECTING ENTRY: The notice filed at D.I. 530 has been removed from the docket per counsel's request. A corrected version will be refiled. (nms)
July 7, 2021 Filing 529 NOTICE of Mylan's Notice of Deposition of Steven Little by Mylan Pharmaceuticals Inc. (Hitch, Cortlan)
July 7, 2021 Opinion or Order Filing 528 SO ORDERED Granting (526 in 19-md-2902-RGA; 100 in 20-cv-749-RGA) STIPULATION and Proposed Order to Amend Case Schedule (*Reset Hearings: A Pretrial Conference is set for 10/29/2021, at 9:00 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 7/7/2021. Associated Cases: 1:20-cv-00749-RGA, 1:19-md-02902-RGA(nms)
July 6, 2021 Filing 527 NOTICE to Take Deposition of Michael Crowley, Ph.D. and William C. Schinzer, Ph.D. on July 7, 2021 and July 9, 2021, respectively filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
July 6, 2021 Filing 526 STIPULATION and Proposed Order to Amend Case Schedule - filed by Apotex Corp., Apotex Inc., Apotex Inc.. (Bilson, David) Modified on 7/6/2021 (nms).
July 2, 2021 Filing 525 NOTICE to Take Deposition of Fabia Gozzo on July 12, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 2, 2021 Filing 524 NOTICE to Take Deposition of Allan S. Myerson on August 3, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 2, 2021 Filing 523 NOTICE to Take Deposition of Stephen R. Little on July 14, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 2, 2021 Filing 522 NOTICE to Take Deposition of Zachary T. Bloomgarden on August 6, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
July 2, 2021 Filing 521 NOTICE to Take Deposition of Steven R. Little, Ph.D. on July 13, 2021 filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
July 2, 2021 Filing 520 NOTICE to Take Deposition of David E. Bugay, Ph.D. on July 16, 2021 filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
July 2, 2021 Filing 519 NOTICE to Take Deposition of Allan S. Myerson, Ph.D. on July 30, 2021 filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
July 2, 2021 Opinion or Order Filing 518 ORAL ORDER: The 9/10/2021 pretrial conference will cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. Ordered by Judge Richard G. Andrews on 7/2/2021. Associated Cases: 1:19-md-02902-RGA et al. (lak)
July 2, 2021 Minute Entry for proceedings held before Judge Richard G. Andrews - T/C Status Conference held on 7/2/2021. Counsel for Plaintiffs: A. Joyce, A. Gaza, E. Ormerod. Counsel for Defendants: K. Dorsney, J. Phillips, D. Gattuso. The 9/10/2021 pretrial conference shall cover invalidity only. A separate pretrial conference will be scheduled to cover infringement. (Court Reporter Stacy Ingram.) Associated Cases: 1:19-md-02902-RGA et al.(lak)
July 1, 2021 Filing 517 NOTICE OF SERVICE of (1) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 7,326,708; (2) Reply Report of G. Patrick Stahly, Ph.D. Regarding Aurobindo's Samples; (3) Reply Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of Aurobindo Samples; (4) Reply Expert Report of Steven R. Little, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 8,414,921 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 1, 2021 Filing 516 NOTICE to Take Deposition of Fabia Gozzo, Ph.D. on July 2, 2021 filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
June 30, 2021 Filing 515 NOTICE to Take Deposition of Steven R. Little, Ph.D. on June 30, 2021 (Remote) filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
June 29, 2021 Filing 514 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding dial-in information for July 2, 2021 status conference. (Silver, Daniel) Modified on 6/30/2021 (nms).
June 29, 2021 Filing 513 NOTICE to Take Deposition of Fabia Gozzo on July 2, 2021 filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
June 29, 2021 Filing 512 NOTICE to Take Deposition of Steven Little on June 30, 2021 filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
June 28, 2021 Filing 511 NOTICE OF SERVICE of (1) Second Set of Requests for Production and Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., and (2) Second Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
June 25, 2021 Filing 510 NOTICE of Remote Deposition of Laird Forrest, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel)
June 25, 2021 Filing 509 NOTICE of Remote Deposition of Jeremy Karl Cockcroft, Ph.D. by Merck Sharp & Dohme Corp. (Silver, Daniel)
June 25, 2021 Filing 508 NOTICE requesting Clerk to remove Guylaine Hache as co-counsel. Reason for request: no longer associated with the case. (Bilson, David)
June 25, 2021 Opinion or Order SO ORDERED, re #507 MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 6/24/2021. (nms)
June 24, 2021 Filing 507 MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for Vanessa O. Omoroghomwan)(Silver, Daniel)
June 16, 2021 Opinion or Order SO ORDERED, re (D.I. 505 in 19-md-02902-RGA; D.I. 11 in 21-cv-182-RGA) STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to July 16, 2021. Signed by Judge Richard G. Andrews on 6/16/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00182-RGA(nms)
June 15, 2021 Filing 506 NOTICE to Take Deposition of S. Craig Dyar, Ph.D. on June 18, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
June 15, 2021 Filing 505 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to July 16, 2021 - filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. (Poff, Adam)
June 14, 2021 Filing 504 NOTICE requesting Clerk to remove Alissa M. Pacchioli as co-counsel.. (Dorsney, Kenneth)
June 14, 2021 Filing 503 NOTICE to Take Deposition of S. Craig Dyar, Ph.D. on June 18, 2021 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
June 14, 2021 Opinion or Order Filing 502 ORDER Setting Mediation Conferences: A Telephone Conference is set for 6/29/2021 at 10:30 AM before Judge Mary Pat Thynge. Counsel for plaintiff to initiate the call to chambers. Signed by Judge Mary Pat Thynge on 6/14/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(Taylor, Daniel)
June 11, 2021 Filing 501 NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraphs 3 and 4 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
June 11, 2021 Filing 500 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
June 11, 2021 Opinion or Order SO ORDERED, re (D.I. 498 in 19-md-2902-RGA; D.I. 9 in 21-cv-824-RGA) Stipulation and Proposed Order Governing Acceptance of Service of Process and Extension of Response to Complaint. Signed by Judge Richard G. Andrews on 6/11/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00824-RGA(nms)
June 10, 2021 Filing 499 NOTICE OF SERVICE of Expert Report of David MacMillan, Ph.D. Regarding Apotex's Infringement of the U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
June 10, 2021 Filing 498 STIPULATION and [Proposed] Order Governing Acceptance of Service of Process and Extension of Response Time to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
June 9, 2021 Filing 497 NOTICE OF SERVICE of Reply Expert Report of S. Craig Dyar, Ph.D. on behalf of Sun Pharmaceutical Industries Ltd. filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
June 9, 2021 Filing 496 NOTICE OF SERVICE of Responsive Expert Report of William E. Mayo, Ph.D. regarding Noninfringement of U.S. Patent No. 7,326,708 [Confidential] filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
June 9, 2021 Filing 495 NOTICE OF SERVICE of Defendant DRL's First Supplemental Response to Plaintiff's First Set of Interrogatories (Nos. 1-2) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
June 9, 2021 Filing 494 DECLARATION of Service as to Defendant S&B Pharma, Inc. made on June 8, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 6/9/2021 (nms).
June 9, 2021 Filing 493 DECLARATION of Service as to Defendant Alkem Laboratories Ltd. made on June 8, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 6/9/2021 (nms).
June 9, 2021 Filing 492 NOTICE OF SERVICE of (1) Reply Expert Report of Steven R. Little, Ph.D. Regarding Suns Infringement of U.S. Patent No. 8,414,921; and (2) Expert Report of David E. Bugay, Ph.D. Regarding Microscopy of Suns ANDA Product filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
June 7, 2021 Filing 491 NOTICE OF SERVICE of Reply Expert Reports filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
June 7, 2021 Filing 490 NOTICE OF SERVICE of (i) Defendants' Reply Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19, and 21-23 of U.S. Patent No. 7,326,70 [CONFIDENTIAL]; and (ii) the Reply Expert Report of Graham Buckton, Ph.D., D.Sc. [CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick)
June 4, 2021 Filing 489 NOTICE OF SERVICE of Reply expert report of S. Craig Dyar, PH.D. filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
June 2, 2021 Filing 488 NOTICE OF SERVICE of 1) Expert Opinion of Joseph H. Reibenspies, Ph.D. and 2) Responsive Expert Report of Ralph Tarantino, R.Ph., Ph.D., in Response to the Opening Expert Report of Steven Little, Ph.D., re: U.S. Patent No. 8,414,921, and Zachary Bloomgarden re: U.S. Patent Nos. 8,414,921 and 7,326,708 filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
June 1, 2021 Filing 487 NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
June 1, 2021 Filing 486 NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
May 28, 2021 Opinion or Order SO ORDERED, Granting (78 in 20-cv-1099-RGA; 74 in 20-cv-949-RGA; 485 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME to Submit Responsive Infringement Reports to May 28, 2021. Signed by Judge Richard G. Andrews on 5/28/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
May 26, 2021 Filing 485 STIPULATION TO EXTEND TIME to Submit Responsive Infringement Reports to May 28, 2021 - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve)
May 25, 2021 Filing 484 NOTICE requesting Clerk to remove Jeffrey Ho as co-counsel.. (Silver, Daniel)
May 25, 2021 Opinion or Order SO ORDERED, Granting (D.I. 483 in 19-md-2902-RGA; D.I. 92 in 20-cv-749-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 5/25/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
May 24, 2021 Filing 483 STIPULATION and [Proposed] Order to Amend Case Schedule by Merck Sharp & Dohme Corp.. (Silver, Daniel)
May 14, 2021 Filing 482 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to June 16, 2021 - filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. (Poff, Adam)
May 14, 2021 Opinion or Order SO ORDERED, re (D.I. 482 in 19-md-2902-RGA; D.I. 10 in 21-cv-182-RGA) STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to June 16, 2021. Signed by Judge Richard G. Andrews on 5/14/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00182-RGA(nms)
May 13, 2021 Filing 481 MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
May 13, 2021 Opinion or Order SO ORDERED, re (D.I. 481 in 19-md-2902-RGA; 182 in 19-cv-1489-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jillian M. Schurr, filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/13/2021. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms)
May 12, 2021 Filing 480 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
May 12, 2021 Opinion or Order Filing 479 ORAL ORDER: The Rule 16(b) Conference scheduled for 5/13/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 5/12/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms)
May 12, 2021 Opinion or Order Filing 478 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2021. Amended Pleadings due by 9/10/2021. Fact Discovery completed by 3/25/2022. A Pretrial Conference is set for 10/14/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/31/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/12/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms)
May 12, 2021 CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(Taylor, Daniel)
May 11, 2021 Filing 477 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding IPR Decision. (Attachments: #1 IPR Decision)(Silver, Daniel)
May 11, 2021 Filing 476 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 5/12/2021 (nms).
May 7, 2021 Filing 475 NOTICE OF SERVICE of (1) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 7,326,708; (2) Opening Expert Report of Steven R. Little, Ph.D. Regarding Aurobindo's Infringement of U.S. Patent No. 8,414,921; (3) Expert Report of Zachary T. Bloomgarden, M.D. Regarding Aurobindo's Infringement; (4) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of Aurobindo Samples; and (5) Report of G. Patrick Stahly, Ph.D. Regarding Aurobindo's Samples filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
May 5, 2021 Filing 474 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s [CONFIDENTIAL] Objections and Responses to Plaintiff's Third Set of Interrogatories filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
May 5, 2021 Filing 473 NOTICE requesting Clerk to remove Julius Jefferson formerly of Goodwin Procter LLP as co-counsel. Reason for request: no longer at the firm. (Gattuso, Dominick)
May 3, 2021 Filing 472 NOTICE of Joinder of Defendants Mylan Pharmaceuticals Inc. and Sun Pharmaceutical Industries Ltd's Opening Expert Report of S. Craig Dyar on Invalidity of U.S. Patent No. 8,414,921 by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve)
May 3, 2021 Pro Hac Vice Attorney John R. McNair for Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA.(kmd)
May 3, 2021 Opinion or Order SO ORDERED, re (D.I. 471 in 19-md-2902-RGA; D.I. 158 in 19-cv-319-RGA) MOTION for Pro Hac Vice Appearance of Attorney John R. McNair, Esq., filed by Sun Pharmaceutical Industries Ltd.. Signed by Judge Richard G. Andrews on 5/3/2021. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
April 30, 2021 Filing 471 MOTION for Pro Hac Vice Appearance of Attorney John R. McNair, Esquire - filed by Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha)
April 29, 2021 Opinion or Order Filing 470 Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/13/2021, at 11:00 AM before Judge Richard G. Andrews (see order for further details). Signed by Judge Richard G. Andrews on 4/29/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms)
April 29, 2021 Filing 469 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 4/29/2021 (nms).
April 29, 2021 Opinion or Order SO ORDERED, re (D.I. 469 in 19-md-2902-RGA; D.I. 73 in 20-cv-1099-RGA; D.I. 69 in 20-cv-949-RGA) STIPULATION and Proposed Order to Extend Time for various deadlines. Signed by Judge Richard G. Andrews on 4/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
April 28, 2021 Filing 468 NOTICE OF SERVICE of Apotex's [CONFIDENTIAL] Responses and Objections to Plaintiff's Second Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
April 28, 2021 Filing 467 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Apotex Inc. and Apotex Corp.s First Set of Interrogatories to Plaintiff (Nos. 1-7) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
April 21, 2021 Filing 466 STIPULATION and [Proposed] Order to Amend Case Schedule by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
April 21, 2021 Filing 465 NOTICE OF SERVICE of Rebuttal Expert Report of Laird Forrest, Ph.D. Regarding Sun's Non-Infringement of the '921 Patent filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
April 21, 2021 Opinion or Order SO ORDERED, re (D.I. 466 in 19-md-2902-RGA; D.I. 86 in 20-cv-749-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 4/21/2021. Associated Cases: 1:20-cv-00749-RGA, 1:19-md-02902-RGA(nms)
April 20, 2021 Filing 464 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc., Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
April 20, 2021 Filing 463 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Worldwide DMCC, Zydus Worldwide DMCC filed by Zydus Worldwide DMCC. (Phillips, John)
April 20, 2021 Filing 462 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Phillips, John)
April 20, 2021 Filing 461 ANSWER to Complaint and Affirmative Defenses, by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Phillips, John) Modified on 4/21/2021 (nms).
April 19, 2021 Filing 460 NOTICE OF SERVICE of (1) Responsive Report of Zachary T. Bloomgarden, M.D. Regarding Validity; (2) Responsive Report of David MacMillan, Ph.D. Regarding Validity; (3) Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validty of U.S. Patent No. 7,326,708; (4) Responsive Report of Adam J. Matzger, Ph.D. Regarding Validity of the 708 Patent; and (5) Confidential Addendum to the Responsive Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent No. 7,326,708 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
April 19, 2021 Filing 459 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing and Christopher J. Cassella - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: #1 Certification of Michael J. Gaertner, #2 Certification of David B. Abramowitz, #3 Certification of Carolyn A. Blessing, #4 Certification of Christopher J. Casella)(Bilson, David)
April 19, 2021 Filing 458 NOTICE OF SERVICE of Rebuttal Expert Report of Jennifer Swift, Ph.D. Regarding Sun's Non-Infringement of U.S. Patent No. 7,326,708 filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
April 19, 2021 Filing 457 NOTICE Of Service of (1) Rebuttal Expert Report of William C. Schinzer, Ph.d. (2) Rebuttal Expert Report of Michael Crowley, Ph.d. (3) Rebuttal Expert Report of Jeremy Karl Cockcroft, Ph. D., filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth) Modified on 4/19/2021 (nms).
April 19, 2021 Opinion or Order SO ORDERED, re (D.I. 15 in 21-cv-315-RGA; D.I. 459 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing and Christopher J. Cassella, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. Signed by Judge Richard G. Andrews on 4/19/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms)
April 16, 2021 Filing 456 STIPULATION TO EXTEND TIME for Sun Pharmaceutical Industries Ltd. to Serve Responsive Expert Reports Regarding Non-Infringement of U.S. Patent No. 8,414,921 and Merck Sharp and Dohme Corp. to Serve Reply Expert Reports Regarding Infringement of U.S. Patent No. 8,414,921 to April 20, 2021 and June 8, 2021 - filed by Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha)
April 16, 2021 Pro Hac Vice Attorney Roshan P. Shrestha for Inventia Healthcare LLC and Inventia Healthcare Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-00182-RGA, 1:19-md-02902-RGA.(kmd)
April 16, 2021 Pro Hac Vice Attorney Stephen R. Auten for Inventia Healthcare LLC and Inventia Healthcare Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-00182-RGA, 1:19-md-02902-RGA.(kmd)
April 16, 2021 Opinion or Order SO ORDERED, re (D.I. 456 in 19-md-2902-RGA; D.I. 154 in 19-cv-319-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 4/16/2021. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
April 15, 2021 Filing 455 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Esquire, and Roshan P. Shrestha, Ph.D., Esquire - filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. (Poff, Adam)
April 15, 2021 Opinion or Order SO ORDERED, re (D.I. 9 in 21-cv-182-RGA; D.I. 455 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten, Esq., and Roshan P. Shrestha, Ph.D., Esq., filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. Signed by Judge Richard G. Andrews on 4/15/2021. Associated Cases: 1:21-cv-00182-RGA, 1:19-md-02902-RGA(nms)
April 14, 2021 Opinion or Order SO ORDERED, re (D.I. 454 in 19-md-2902-RGA; D.I. 8 in 21-cv-182-RGA) STIPULATION and Proposed Order for Extension of Time to Respond to the Complaint to May 17, 2021. Signed by Judge Richard G. Andrews on 4/14/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00182-RGA(nms)
April 13, 2021 Filing 454 STIPULATION and Proposed Order for Extension of Time to Respond to the Complaint - filed by Inventia Healthcare LLC, Inventia Healthcare Ltd.. (Poff, Adam) Modified on 4/14/2021 (nms).
April 13, 2021 Filing 453 NOTICE OF SERVICE of (1) Opening Expert Report of Allan S. Myerson, Ph.D. Regarding DRL's Infringement of U.S. Patent No. 7,326,708; (2) Expert Report of Fabia Gozzo, Ph.D. Regarding S-XRPD Testing of DRL Samples; (3) Expert Report of Zachary T. Bloomgarden, M.D. Regarding DRL's Infringement; (4) Report of G. Patrick Stahly, Ph.D. Regarding DRL's Samples filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
April 13, 2021 Opinion or Order Filing 452 SO ORDERED Granting (D.I. 450 in 19-md-2902-RGA; D.I. 83 in 20-cv-749-RGA) Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 4/13/2021. Associated Cases: 1:20-cv-00749-RGA, 1:19-md-02902-RGA(nms)
April 13, 2021 Filing 451 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 4/13/2021 (nms).
April 13, 2021 Filing 450 STIPULATION and [Proposed] Order Regarding Claim Construction by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
April 13, 2021 Opinion or Order SO ORDERED, Granting (D.I. 67 in 20-cv-949-RGA; D.I. 71 in 20-cv-1099-RGA; D.I. 451 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 4/13/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
April 12, 2021 Filing 449 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s Objections and Responses to Plaintiff's Second Set of Requests for Production filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
April 2, 2021 Filing 448 NOTICE OF SERVICE of (1) Plaintiff Merck Sharp & Dohme Corp.'s Claim Construction Issue Identification (U.S. Patent No. 7,468,459), and (2) Third Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Apotex Inc. and Apotex Corp. (Nos. 10-15) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 31, 2021 Filing 447 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Initial Invalidity Contentions Relating to U.S. Patent No. 7,468,459 filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
March 31, 2021 Filing 446 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
March 31, 2021 Filing 445 STIPULATION and Proposed Order for Extension of Time for the close of Fact Discovery and to Serve Supplemental Infringement Contentions to April 16, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/31/2021 (nms).
March 31, 2021 Filing 444 REDACTED VERSION of #441 Order, by Sandoz Inc.. (Gattuso, Dominick) Modified on 3/31/2021 (nms).
March 31, 2021 Opinion or Order SO ORDERED, re (70 in 20-cv-1099-RGA; 66 in 20-cv-949-RGA; 445 in 19-md-2902-RGA) STIPULATION and Proposed Order for Extension of Time for the close of Fact Discovery and to Serve Supplemental Infringement Contentions to April 16, 2021. Signed by Judge Richard G. Andrews on 3/31/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
March 30, 2021 Filing 443 STIPULATION TO EXTEND TIME for the parties to exchange initial Infringement Contentions and initial Invalidity Contentions for the '459 patent to March 31, 2021 - filed by Apotex Corp., Apotex Inc., Apotex Inc.. (Bilson, David)
March 30, 2021 Opinion or Order SO ORDERED, re (78 in 20-cv-749-RGA; 443 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time for the parties to exchange initial Infringement Contentions and initial Invalidity Contentions for the '459 patent to March 31, 2021. Signed by Judge Richard G. Andrews on 3/30/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
March 26, 2021 Filing 442 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Apotex's First Set of Requests for the Production of Documents and Things (Nos. 1-8) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 26, 2021 Opinion or Order Filing 441 [SEALED] ORDER Granting (440 in 19-md-2902-RGA; 147 in 19-cv-312-RGA) Stipulation and Proposed Order Regarding Fact Discovery Between Merck and Sandoz. Signed by Judge Richard G. Andrews on 3/26/2021.This order has been emailed to local counsel. Associated Cases: 1:19-cv-00312-RGA, 1:19-md-02902-RGA(nms)
March 25, 2021 Filing 440 [SEALED] STIPULATION and Proposed Order Regarding Fact Discovery Between Merck and Sandoz, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/26/2021 (nms).
March 24, 2021 Filing 439 NOTICE OF SERVICE of Apotex's First Set of [Confidential] Interrogatories to Plaintiff (Nos. 1-7) filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
March 24, 2021 Filing 438 ANSWER to #418 Answer to Amended Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 24, 2021 Filing 437 ANSWER to #419 Answer to Amended Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 22, 2021 Filing 436 NOTICE of Joinder by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve)
March 19, 2021 Filing 435 NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Third Set of Interrogatories filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
March 19, 2021 Filing 434 NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
March 19, 2021 Filing 433 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
March 19, 2021 Filing 432 Amended NOTICE of Deposition for Stuart Green by Merck Sharp & Dohme Corp. (Silver, Daniel)
March 19, 2021 Filing 431 NOTICE OF SERVICE of Second Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 19, 2021 Filing 430 STIPULATION and [Proposed] Order to Amend Case Schedule by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
March 19, 2021 Filing 429 DECLARATION of Service made on Defendant Cadila Healthcare Ltd. on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms).
March 19, 2021 Filing 428 DECLARATION of Service made on Defendant Zydus Pharmaceuticals (USA) Inc. on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms).
March 19, 2021 Filing 427 DECLARATION of Service made on Defendant Zydus Worldwide DMCC on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms).
March 19, 2021 Filing 426 STIPULATION and [Proposed] Order Governing Service of Process and Response Time to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
March 19, 2021 Opinion or Order SO ORDERED, re (7 in 21-cv-315-RGA; 426 in 19-md-2902-RGA) Stipulation and Proposed Order Governing Service of Process and Response Time to Complaint (*Reset Answer Deadline: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Cadila Healthcare Ltd. answers due by 4/19/2021). Signed by Judge Richard G. Andrews on 3/19/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms)
March 19, 2021 Opinion or Order SO ORDERED, re (72 in 20-cv-749-RGA; 430 in 19-md-2902-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 3/19/2021. Associated Cases: 1:20-cv-00749-RGA, 1:19-md-02902-RGA(nms)
March 18, 2021 Opinion or Order Filing 425 SO ORDERED, re (424 in 19-md-2902-RGA; 145 in 19-cv-312-RGA) Stipulation and Proposed Order Regarding Infringement. Signed by Judge Richard G. Andrews on 3/18/2021. Associated Cases: 1:19-cv-00312-RGA, 1:19-md-02902-RGA(nms)
March 17, 2021 Filing 424 STIPULATION and [Proposed] Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Silver, Daniel)
March 12, 2021 Filing 423 NOTICE OF SERVICE of Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Apotex Inc. and Apotex Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 11, 2021 Filing 422 AMENDED CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 3/11/2021. Associated Cases: 1:19-cv-00347-RGA, 1:19-md-02902-RGA, 1:20-cv-00776-RGA(nms)
March 11, 2021 Filing 421 STIPULATION TO EXTEND TIME The Deadline for the Parties to Serve Supplemental Infringement and Invalidity Contentions to March 19, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
March 11, 2021 Opinion or Order SO ORDERED, re (D.I. 65 in 20-cv-847-RGA; D.I. 421 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time to Serve Supplemental Infringement and Invalidity Contentions to March 19, 2021. Signed by Judge Richard G. Andrews on 3/11/2021. Associated Cases: 1:20-cv-00847-RGA, 1:19-md-02902-RGA(nms)
March 10, 2021 Filing 420 PROPOSED Amended Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/10/2021 (nms).
March 4, 2021 Filing 419 ANSWER to #396 Amended Complaint with Affirmative Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Apotex Corp., Apotex Inc..(Phillips, John) Modified on 3/4/2021 (nms).
March 3, 2021 Filing 418 ANSWER to #391 Amended Complaint and Additional Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited.(Ormerod, Eve) Modified on 3/3/2021 (nms).
March 3, 2021 Opinion or Order Filing 417 SO ORDERED Granting (63 in 20-cv-949-RGA; 63 in 20-cv-847-RGA; 416 in 19-md-2902-RGA; 151 in 19-cv-313-RGA; 138 in 19-cv-314-RGA; 177 in 19-cv-1489-RGA; 30 in 20-cv-1496-RGA; 68 in 20-cv-749-RGA; 65 in 20-cv-1099-RGA; 143 in 19-cv-312-RGA; 55 in 20-cv-815-RGA; 151 in 19-cv-319-RGA) Stipulation and Proposed Order Regarding Corrected Asserted Claims. Signed by Judge Richard G. Andrews on 3/3/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms)
March 3, 2021 Filing 416 STIPULATION and [Proposed] Order Regarding Corrected Asserted Claims by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
March 2, 2021 Filing 415 CONSENT JUDGMENT between Merck Sharp & Dohme Corp. and Anchen Pharmaceuticals, Inc. and Par Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/2/2021. (nms)
March 1, 2021 Filing 414 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/2/2021 (nms).
March 1, 2021 Opinion or Order Filing 413 SO ORDERED Granting (D.I. 412 in 19-md-2902-RGA; D.I. 61 in 20-cv-847-RGA) Stipulation and Proposed Order Regarding Completion of Deposition After Fact Discovery Deadline. Signed by Judge Richard G. Andrews on 3/1/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
March 1, 2021 Filing 412 STIPULATION and [Proposed] Order Regarding Completion of Deposition After Fact Discovery Deadline by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
February 26, 2021 Filing 411 NOTICE OF SERVICE of Plaintiffs Amended Paragraph 4 Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 26, 2021 Filing 410 NOTICE requesting Clerk to remove Zachary B. Cohen as co-counsel.. (Wilson, Samantha)
February 25, 2021 Opinion or Order SO ORDERED, re (D.I. 62 in 20-cv-949-RGA; D.I. 64 in 20-cv-1099-RGA; D.I. 409 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 2/25/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
February 24, 2021 Filing 409 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 2/25/2021 (nms).
February 24, 2021 Filing 408 NOTICE OF SERVICE of Apotex's First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-8) filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
February 24, 2021 Filing 407 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s First Set of Interrogatories (Nos. 1-8) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
February 24, 2021 Opinion or Order Filing 406 SO ORDERED Granting (D.I. 148 in 19-cv-319-RGA; D.I. 405 in 19-md-2902-RGA) Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 2/24/2021. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
February 24, 2021 Filing 405 STIPULATION and [Proposed] Order by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
February 23, 2021 Filing 404 NOTICE OF SERVICE of Third Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendant Sun Pharmaceutical Industries Ltd. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
February 22, 2021 Filing 403 NOTICE OF SERVICE of Opening Expert Reports filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 22, 2021 Filing 402 NOTICE OF SERVICE of All Defendants' Opening Expert Report of Graham Buckton, Ph.D., D.Sc. filed by Sandoz Inc..(Gattuso, Dominick)
February 19, 2021 Filing 401 NOTICE OF SERVICE of Opening Expert Report of Leonard J. Chyall, Ph.D. Concerning Invalidity of Claims 1-3, 17, 19 and 21-23 of U.S. Patent No. 7,326,708 filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
February 19, 2021 Filing 400 NOTICE OF SERVICE of Mylan and Sun's Opening Expert Report of S. Craig Dyar on Invalidity filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
February 19, 2021 Filing 399 REDACTED VERSION of #392 Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/19/2021 (nms).
February 19, 2021 Opinion or Order Filing 398 SO ORDERED Granting (D.I. 397 in 19-md-2902-RGA; D.I. 147 in 19-cv-313-RGA; D.I. 60 in 20-cv-749-RGA) Stipulation and Proposed Order Regarding Infringement. Signed by Judge Richard G. Andrews on 2/19/2021. Associated Cases: 1:19-cv-00313-RGA, 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
February 18, 2021 Filing 397 STIPULATION and Proposed Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
February 18, 2021 Filing 396 [SEALED] FIRST AMENDED COMPLAINT against Apotex Corp. and Apotex Inc.- filed by Merck Sharp & Dohme Corp..(nms)
February 18, 2021 Opinion or Order Filing 395 [SEALED] ORDER Granting (D.I. 55 in 20-cv-749-RGA; D.I. 392 in 19-md-2902-RGA) Stipulation and Proposed Order Regarding First Amended Complaint.. Signed by Judge Richard G. Andrews on 2/18/2021.*This order has been emailed to local counsel. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
February 17, 2021 Filing 394 NOTICE OF SERVICE of Plaintiff's Rule 26 and Paragraph 3 Initial Disclosures Regarding the '459 Patent filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 17, 2021 Filing 393 NOTICE OF SERVICE of (1) Apotex's Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and (2) Apotex's Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
February 17, 2021 Filing 392 [SEALED] STIPULATION and [Proposed] Order Regarding Plaintiff Merck Sharp & Dohme Corp.'s First Amended Complaint by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Certificate of Service)(Silver, Daniel)
February 17, 2021 Filing 391 FIRST AMENDED COMPLAINT against Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.- filed by Merck Sharp & Dohme Corp..(nms)
February 17, 2021 Opinion or Order Filing 390 SO ORDERED Granting (D.I. 389 in 19-md-2902-RGA; D.I. 58 in 20-cv-1099-RGA) Stipulation and Proposed Order Regarding First Amended Complaint. Signed by Judge Richard G. Andrews on 2/17/2021. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01099-RGA(nms)
February 16, 2021 Filing 389 STIPULATION and [Proposed] Order Regarding Plaintiff Merck Sharp & Dohme Corp's First Amended Complaint by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Silver, Daniel)
February 16, 2021 Filing 388 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Second Supplemental Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
February 15, 2021 Filing 387 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendant Aurobindo Pharma USA Inc.'s and Aurobindo Pharma Ltd.'s Notice of Deposition Under Rule 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
February 12, 2021 Filing 386 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharpe & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
February 10, 2021 Filing 385 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Certificate of Correction. (Attachments: #1 Certificate of Correction)(Silver, Daniel)
February 9, 2021 Filing 384 REDACTED VERSION of #382 Notice to Take Deposition, by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) Modified on 2/9/2021 (nms).
February 5, 2021 Filing 383 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Joyce, Alexandra)
February 2, 2021 Filing 382 [SEALED] NOTICE to Take Deposition of Merck Sharpe & Dohme Corp. on February 12, 2021 at 9:00 a.m. EST filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited.(Ormerod, Eve)
February 1, 2021 Filing 381 CONSENT JUDGMENT between Plaintiff and Lupin Limited and Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 1/29/2021. (nms)
February 1, 2021 Opinion or Order Filing 380 SO ORDERED Granting (D.I. 24 in 20-cv-1496-RGA; D.I. 377 in 19-md-2902-RGA) Stipulation and Proposed Order Regarding Infringement. Signed by Judge Richard G. Andrews on 1/29/2021. Associated Cases: 1:20-cv-01496-RGA, 1:19-md-02902-RGA(nms)
February 1, 2021 Opinion or Order SO ORDERED, re (D.I. 56 in 20-cv-00847-RGA; D.I. 379 in 19-md-2902-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 2/1/2021. Associated Cases: 1:20-cv-00847-RGA, 1:19-md-02902-RGA(nms)
January 29, 2021 Filing 379 STIPULATION and [Proposed] Order to Amend Case Schedule by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
January 29, 2021 Filing 378 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 1/29/2021 (nms).
January 29, 2021 Filing 377 STIPULATION and Proposed Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
January 28, 2021 Filing 376 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding certificate of correction. (Silver, Daniel) Modified on 1/28/2021 (nms).
January 26, 2021 Filing 375 NOTICE OF SERVICE of First Set of Interrogatories to Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
January 25, 2021 Opinion or Order SO ORDERED, re (23 in 20-cv-1496-RGA; 51 in 20-cv-949-RGA; 374 in 19-md-2902-RGA; 138 in 19-cv-312-RGA; 54 in 20-cv-847-RGA; 141 in 19-cv-319-RGA; 50 in 20-cv-815-RGA; 52 in 20-cv-749-RGA; 144 in 19-cv-313-RGA; 148 in 19-cv-311-RGA; 170 in 19-cv-1489-RGA; 64 in 20-cv-776-RGA; 132 in 19-cv-314-RGA; 142 in 19-cv-347-RGA; 50 in 20-cv-1099-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 1/25/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
January 25, 2021 Pro Hac Vice Attorney Jeffrey G. Ho for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al.(kmd)
January 22, 2021 Filing 374 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Ho - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification of Jeffrey Ho)(Silver, Daniel)
January 22, 2021 Filing 373 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
January 15, 2021 Filing 372 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.'s First Set of Requests for the Production of Documents and Things (Nos. 1-21) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
January 14, 2021 Filing 371 NOTICE OF SERVICE of Defendant DRL's Response to Plaintiff's Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) [Confidential] filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Moore, David)
January 12, 2021 CORRECTING ENTRY: The pdf for D.I. #370 has been replaced with a corrected version. The NEF for the filing has been regenerated. (nms)
January 11, 2021 Opinion or Order Filing 370 TRIAL SCHEDULING ORDER: Bench trials with Plaintiff and Defendants Ajanta (C.A. 20-1496-RGA), Apotex (C.A. 19-313-RGA; 20cv749-RGA) and Aurobindo (C.A. 20-949-RGA; C.A. 20-1099-RGA) are set to start at 8:30 am on November 22, 2021, and end on November 24, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. Bench trials with Plaintiff and Defendants Dr. Reddys (C.A. 20-847-RGA), Lupin (C.A. 19-347-RGA; C.A. 20-776-RGA) and Zydus (C.A. 19-314-RGA) are set to start at 8:30 am on December 27, 2021, and end on December 29, 2021. The exact order for which case will be proceeding first, second, and third is yet to be determined. A bench trial between Plaintiff and Defendant Sun (C.A. 19-319-RGA) will start at 8:30 am on January 3, 2022, and conclude on January 4, 2022. A telephone status conference is set for July 2, 2021, at 8:30 am. Plaintiffs local counsel shall coordinate the call and file the dial-in information no later than 48 hours before the conference. Signed by Judge Richard G. Andrews on 1/11/2021. Associated Cases: 1:19-cv-00311-RGA et al.(nms) Modified on 1/12/2021 (nms). (Main Document 370 replaced on 1/12/2021) (nms).
January 8, 2021 Filing 369 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding a status update regarding infringement trials. (Silver, Daniel) Modified on 1/8/2021 (nms).
January 8, 2021 Filing 368 NOTICE OF SERVICE of Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s [CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures and Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s [CONFIDENTIAL] Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
January 8, 2021 Filing 367 NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
January 7, 2021 Filing 366 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
January 5, 2021 Filing 365 Amended Notice of Depositions, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 1/6/2021 (nms).
January 4, 2021 Filing 364 Letter to The Honorable Richard G. Andrews, from Daniel M. Silver, Esq., regarding certificate of correction. (Silver, Daniel) Modified on 1/4/2021 (nms).
December 30, 2020 Filing 363 NOTICE OF SERVICE of Plaintiff's Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
December 28, 2020 Opinion or Order Filing 362 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 3/12/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01496-RGA(nms)
December 23, 2020 Filing 361 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. , regarding certificate of correction. (Silver, Daniel) Modified on 12/23/2020 (nms).
December 22, 2020 Filing 360 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/22/2020 (nms).
December 22, 2020 Filing 359 STIPULATION and Proposed Order to Extend Time for Substantial Completion of Document Production to January 21, 2021 - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve) Modified on 12/22/2020 (nms).
December 22, 2020 Opinion or Order SO ORDERED, re (D.I. 43 in 20-cv-1099-RGA; D.I. 44 in 20-cv-949-RGA; D.I. 359 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to January 21, 2021. Signed by Judge Richard G. Andrews on 12/22/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
December 21, 2020 Filing 358 NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories to Lupin (No. 1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra)
December 21, 2020 Filing 357 STIPULATION and [Proposed] Order to Amend Case Schedule by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
December 21, 2020 Opinion or Order SO ORDERED Granting (D.I. 357 in 19-md-2902-RGA; D.I. 47 in 20-cv-847-RGA) Stipulation and Proposed Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 12/21/2020. Associated Cases: 1:20-cv-00847-RGA, 1:19-md-02902-RGA(nms)
December 18, 2020 Filing 356 NOTICE OF SERVICE of (1) Plaintiff's Responses and Objections to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s First Set of Interrogatories (Nos. 1-2) and (2) Plaintiff's Responses and Objections to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s First Set of Requests for the Production of Documents and Things (Nos. 1-8) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
December 18, 2020 Opinion or Order Filing 355 SO ORDERED Granting (44 in 20-cv-847-RGA; 354 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 12/18/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
December 17, 2020 Filing 354 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/18/2020 (nms).
December 17, 2020 Filing 353 REDACTED VERSION of #344 Stipulation, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/17/2020 (nms).
December 17, 2020 Filing 352 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz and Guylaine Hache - filed by Apotex Corp., Apotex Inc., Apotex Inc.. (Attachments: #1 Janusz Pro Hac Certification, #2 Hache Pro Hac Certification)(Bilson, David)
December 17, 2020 Filing 351 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 12/17/2020 (nms).
December 17, 2020 Opinion or Order SO ORDERED, re (136 in 19-cv-347-RGA; 59 in 20-cv-776-RGA; 42 in 20-cv-1099-RGA; 45 in 20-cv-815-RGA; 46 in 20-cv-749-RGA; 143 in 19-cv-311-RGA; 43 in 20-cv-949-RGA; 132 in 19-cv-312-RGA; 139 in 19-cv-313-RGA; 126 in 19-cv-314-RGA; 165 in 19-cv-1489-RGA; 136 in 19-cv-319-RGA; 351 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 12/17/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
December 17, 2020 Opinion or Order SO ORDERED, re (352 in 19-md-2902-RGA; 47 in 20-cv-749-RGA) MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz and Guylaine Hache, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 12/17/2020. Associated Cases: 1:20-cv-00749-RGA, 1:19-md-02902-RGA(nms)
December 16, 2020 Filing 350 NOTICE OF SERVICE of First Set of Requests for Documents and Things (Nos. 1-21) to Plaintiff Merck Sharp & Dohme Corp. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
December 16, 2020 Opinion or Order Filing 349 SO ORDERED Granting (D.I. 348 in 19-md-2902-RGA; D.I. 163 in 19-cv-1489-RGA) Joint Stipulation and Proposed Order Concerning Admissibility of Evidence. Signed by Judge Richard G. Andrews on 12/16/2020. Associated Cases: 1:19-cv-01489-RGA, 1:19-md-02902-RGA(nms)
December 15, 2020 Filing 348 Joint STIPULATION and [Proposed] Order Concerning Admissibility of Evidence by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
December 14, 2020 Opinion or Order SO ORDERED, re (346 in 19-md-2902-RGA; 43 in 20-cv-847-RGA) STIPULATION TO EXTEND TIME for joinder of other parties and amendment of pleadings to January 22, 2021. Signed by Judge Richard G. Andrews on 12/14/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
December 11, 2020 Filing 347 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
December 11, 2020 Filing 346 STIPULATION TO EXTEND TIME for joinder of other parties and amendment of pleadings to January 22, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
December 11, 2020 Opinion or Order Filing 345 [SEALED] ORDER Granting (130 in 19-cv-312-RGA; 344 in 19-md-2902-RGA) Sealed Stipulation Regarding Infringement. Signed by Judge Richard G. Andrews on 12/11/2020.This order has been emailed to local counsel. Associated Cases: 1:19-cv-00312-RGA, 1:19-md-02902-RGA(nms)
December 11, 2020 Filing 344 [SEALED] STIPULATION and Proposed Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Silver, Daniel)
December 10, 2020 Filing 343 Amended Notice of Deposition of Abhijit Deshmukh, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/11/2020 (nms).
December 10, 2020 Filing 342 CONSENT JUDGMENT between Merk Sharp & Dohme Corp. and Unichem Laboratories Limited and Unichem Pharmaceuticals (USA). Signed by Judge Richard G. Andrews on 12/10/2020. (nms)
December 9, 2020 Filing 341 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/10/2020 (nms).
December 7, 2020 Filing 340 STIPULATION TO EXTEND TIME the Deadline for Unichem to Answer, Move, or Otherwise Respond to the Complaint to December 21, 2020 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
December 7, 2020 Opinion or Order SO ORDERED, re (340 in 19-md-2902-RGA; 24 in 20-cv-1227-RGA) STIPULATION TO EXTEND Deadline for Unichem to Answer, Move, or Otherwise Respond to the Complaint to December 21, 2020. Signed by Judge Richard G. Andrews on 12/7/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01227-RGA(nms)
December 4, 2020 Filing 339 NOTICE OF SERVICE of 1) Defendant Sun Pharmaceutical Industries Ltd.'s First Supplemental Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-4 and 6) and 2) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's Second Set of Interrogatories (Nos. 7-9) filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
December 4, 2020 Filing 338 NOTICE OF SERVICE of (1) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Requests for Admission to Plaintiff (Nos. 1-9) and (2) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Interrogatories to Plaintiff (Nos. 1-5) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
December 3, 2020 Filing 337 NOTICE OF SERVICE of (i) Sandoz Inc.'s First Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) [HIGHY CONFIDENTIAL]; and, (ii) Sandoz Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 7-9) [HIGHLY CONFIDENTIAL] filed by Sandoz Inc..(Gattuso, Dominick)
December 2, 2020 Filing 336 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
December 1, 2020 Filing 335 NOTICE OF SERVICE of 1) Aurobindo's Responses and Objections to Plaintiff's First Set of Interrogatories and 2) Aurobindo's Responses and Objections to Plaintiff's First Set of Requests for Production filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
November 30, 2020 Filing 334 Amended NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
November 24, 2020 Filing 333 NOTICE OF SERVICE of Ajanta Pharma Limited and Ajanta Pharmaceuticals (USA) Inc.'s [CONFIDENTIAL - PROTECTIVE ORDER MATERIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s Second Set of Interrogatories (Nos. 7-9) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
November 24, 2020 Filing 332 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/24/2020 (nms).
November 24, 2020 Opinion or Order SO ORDERED, re (40 in 20-cv-949-RGA; 332 in 19-md-2902-RGA; 39 in 20-cv-1099-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 11/24/2020. Associated Cases: 1:20-cv-00949-RGA, 1:19-md-02902-RGA, 1:20-cv-01099-RGA(nms)
November 23, 2020 Filing 331 STIPULATION and [Proposed] Order by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 23, 2020 Opinion or Order Filing 330 SO ORDERED Granting Stipulation and Proposed Order Regarding Authenticity of Documents. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
November 23, 2020 Opinion or Order SO ORDERED, re (131 in 19-cv-319-RGA; 327 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time discovery deadlines. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
November 23, 2020 Opinion or Order SO ORDERED re (331 in 19-md-2902-RGA; 128 in 19-cv-312-RGA) Stipulation and Proposed Order extending certain discovery deadlines. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00312-RGA, 1:19-md-02902-RGA(nms)
November 20, 2020 Filing 329 STIPULATION and Proposed Order Regarding Authenticity of Documents, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms).
November 20, 2020 Filing 328 REDACTED VERSION of #306 Stipulation, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms).
November 20, 2020 Filing 327 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms).
November 20, 2020 Filing 326 NOTICE to Take Deposition of Bharat Metkar on 12/7/2020 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
November 20, 2020 Filing 325 NOTICE OF SERVICE of (1) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories to Lupin (Nos. 1-6) and (2) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatoriese to Lupin (Nos. 7-9) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra)
November 20, 2020 Filing 324 Amended NOTICE of Depositions by Merck Sharp & Dohme Corp. (Joyce, Alexandra)
November 20, 2020 Filing 323 NOTICE OF SERVICE of Mylan's Response to Plaintiff's Second Set of Interrogatories (Nos. 7-9) filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
November 20, 2020 Filing 322 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s Objections and Responses to Plaintiff's Second Set of Interrogatories filed by Apotex Corp., Apotex Inc..(Bilson, David)
November 20, 2020 Filing 321 NOTICE OF SERVICE of Defendants Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 7-9) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
November 20, 2020 Filing 320 NOTICE OF SERVICE of Defendant DRL's Responses To Plaintiff's Second Set Of Interrogatories (Nos. 7-9) [Confidential Subject To Protective Order] filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
November 20, 2020 Filing 319 NOTICE of Withdrawal of Certain Delaware Counsel by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Ormerod, Eve)
November 20, 2020 Filing 318 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/20/2020 (nms).
November 20, 2020 Filing 317 STIPULATION and [Proposed] Order by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 20, 2020 Filing 316 NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s Second Set of Interrogatories (Nos. 7-9) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
November 20, 2020 Opinion or Order SO ORDERED, re (40 in 20-cv-749-RGA; 314 in 19-md-2902-RGA; 132 in 19-cv-313-RGA) STIPULATION TO EXTEND TIME to Serve Supplemental Infringement Contentions to December 11, 2020. Signed by Judge Richard G. Andrews on 11/20/2020. Associated Cases: 1:19-cv-00313-RGA, 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
November 20, 2020 Opinion or Order SO ORDERED, re #318 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Unichem Laboratories Limited answer due 12/7/2020; Unichem Pharmaceuticals (USA) Inc. answer due 12/7/2020). Signed by Judge Richard G. Andrews on 11/20/2020. (nms)
November 20, 2020 Opinion or Order SO ORDERED, re (158 in 19-cv-1489-RGA; 130 in 19-cv-319-RGA; 130 in 19-cv-347-RGA; 133 in 19-cv-313-RGA; 123 in 19-cv-314-RGA; 137 in 19-cv-311-RGA; 317 in 19-md-2902-RGA; 54 in 20-cv-776-RGA; 1 in 20-cv-749-RGA) Stipulation and Proposed Order regarding depositions. Signed by Judge Richard G. Andrews on 11/20/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
November 19, 2020 Filing 315 NOTICE OF SERVICE of Sun's Rule 26(a)(1) Amended Disclosures filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
November 19, 2020 Filing 314 STIPULATION TO EXTEND TIME Merck's Deadline to Serve Supplemental Infringement Contentions to December 11, 2020 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 18, 2020 Filing 313 REDACTED VERSION of #301 Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/19/2020 (nms).
November 18, 2020 Filing 312 NOTICE OF SERVICE of Defendant DRL's First Set of Individual Interrogatories to Plaintiff (Nos. 1-2), and Defendant DRL's First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-8) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
November 18, 2020 Filing 311 Amended Notice of Depositions by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/19/2020 (nms).
November 17, 2020 Filing 310 MEMORANDUM OPINION providing claim construction for various terms in U.S. Patent Nos. 7,326,708 and 8,414,921. Signed by Judge Richard G. Andrews on 11/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
November 16, 2020 Filing 309 NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Anchens Second Set of Interrogatories (Nos. 3-4) and (2) Plaintiffs Responses and Objections to Anchens Second Set of Requests for Production of Document and Things (No. 4) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
November 13, 2020 Opinion or Order Filing 308 [SEALED] ORDER Granting (132 in 19-cv-311-RGA; 306 in 19-md-2902-RGA) Sealed Stipulation and [Proposed] Order to Partially Stay the Case. Signed by Judge Richard G. Andrews on 11/13/2020.This order has been emailed to local counsel. Associated Cases: 1:19-cv-00311-RGA, 1:19-md-02902-RGA(nms)
November 13, 2020 Filing 307 NOTICE OF SERVICE of Mylan's First Supplemental Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
November 13, 2020 Filing 306 [SEALED] STIPULATION and [Proposed] Order to Partially Stay the Case by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 12, 2020 Filing 305 REDACTED VERSION of #292 Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms).
November 12, 2020 Filing 304 REDACTED VERSION of #291 Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms).
November 12, 2020 Filing 303 REDACTED VERSION of #286 Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms).
November 12, 2020 Filing 302 REDACTED VERSION of #294 Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/12/2020 (nms).
November 11, 2020 Filing 301 [SEALED] NOTICE OF SERVICE of Subpoena filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Joyce, Alexandra)
November 11, 2020 Filing 300 Amended NOTICE of Deposition by Merck Sharp & Dohme Corp. (Joyce, Alexandra)
November 10, 2020 Opinion or Order Filing 299 ORDER Granting (185 in 19-cv-318-RGA; 296 in 19-md-2902-RGA) Proposed Consent Judgment. Signed by Judge Richard G. Andrews on 11/10/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
November 10, 2020 Opinion or Order Filing 298 ORDER Granting (151 in 19-cv-317-RGA; 295 in 19-md-2902-RGA) Proposed Consent Judgment. Signed by Judge Richard G. Andrews on 11/10/2020. Associated Cases: 1:19-cv-00317-RGA, 1:19-md-02902-RGA(nms)
November 10, 2020 Filing 297 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
November 10, 2020 Filing 296 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 11/10/2020 (nms).
November 10, 2020 Filing 295 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 11/10/2020 (nms).
November 9, 2020 Filing 294 [SEALED] NOTICE OF SERVICE of Subpoena filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel)
November 9, 2020 CORRECTING ENTRY: D.I. 290 has been removed from the docket per counsel's request. A corrected notice will be filed. (nms)
November 6, 2020 Filing 293 MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for Sarahi Uribe)(Silver, Daniel)
November 6, 2020 Opinion or Order SO ORDERED, re (32 in 20-cv-847-RGA; 48 in 20-cv-776-RGA; 293 in 19-md-2902-RGA; 116 in 19-cv-314-RGA; 31 in 20-cv-949-RGA; 126 in 19-cv-313-RGA; 121 in 19-cv-319-RGA; 35 in 20-cv-815-RGA; 30 in 20-cv-1099-RGA; 16 in 20-cv-1227-RGA; 183 in 19-cv-318-RGA; 124 in 19-cv-311-RGA; 123 in 19-cv-347-RGA; 149 in 19-cv-1489-RGA; 149 in 19-cv-317-RGA; 34 in 20-cv-749-RGA; 120 in 19-cv-312-RGA) MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe. Signed by Judge Richard G. Andrews on 11/6/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
November 6, 2020 Pro Hac Vice Attorney Sarahi Uribe for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al. (kmd)
November 5, 2020 Filing 292 [SEALED] NOTICE OF SERVICE of Subpoena filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel)
November 5, 2020 Filing 291 [SEALED] NOTICE OF SERVICE of Subpoenas filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Cerificate of Service)(Silver, Daniel)
November 4, 2020 Filing 289 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
November 4, 2020 Opinion or Order Filing 288 SO ORDERED Granting (285 in 19-md-2902-RGA; 30 in 20-cv-815-RGA) Stipulation and Proposed Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00815-RGA(nms)
November 4, 2020 Opinion or Order Filing 287 SO ORDERED Granting (29 in 20-cv-815-RGA; 284 in 19-md-2902-RGA) Stipulation Regarding Authenticity of Documents. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00815-RGA(nms)
November 4, 2020 Filing 286 [SEALED] NOTICE OF SERVICE of Subpoenas filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel)
November 4, 2020 Filing 285 STIPULATION and Proposed Order Regarding Infringement by Merck Sharp & Dohme Corp.. (Silver, Daniel)
November 4, 2020 Filing 284 STIPULATION Regarding Authenticity of Documents by Merck Sharp & Dohme Corp.. (Joyce, Alexandra)
November 4, 2020 Filing 283 MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for Jihad Komis)(Silver, Daniel)
November 4, 2020 Filing 282 MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick, Esquire - filed by Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha)
November 4, 2020 Filing 281 NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
November 4, 2020 Opinion or Order SO ORDERED, re (282 in 19-md-02902-RGA; 117 in 19-cv-319-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick, Esq., filed by Sun Pharmaceutical Industries Ltd.. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
November 4, 2020 Opinion or Order SO ORDERED, re (123 in 19-cv-313-RGA; 146 in 19-cv-317-RGA; 45 in 19-cv-00347-RGA; 119 in 19-cv-311-RGA; 283 in 19-md-2902-RGA; 117 in 19-cv-312-RGA; 180 in 19-cv-318-RGA; 28 in 20-cv-949-RGA; 27 in 20-cv-1099-RGA; 31 in 20-cv-749-RGA; 28 in 20-cv-815-RGA; 118 in 19-cv-00319-RGA; 29 in 20-cv-847-RGA; 113 in 19-cv-314-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
November 2, 2020 Filing 280 Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding Merck's letter dated 10/30/2020. (Gattuso, Dominick) Modified on 11/3/2020 (nms).
November 2, 2020 Filing 279 NOTICE OF SERVICE of Apotex's [HIGHLY CONFIDENTIAL] Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Apotex Corp., Apotex Inc..(Bilson, David)
October 30, 2020 Filing 278 NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions [Confidential-Subject to Stipulated Protective Order] filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
October 30, 2020 Filing 277 Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding Certificate of Correction. (Silver, Daniel)
October 30, 2020 Filing 276 Notice of Joinder, by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve) Modified on 10/30/2020 (nms).
October 29, 2020 Filing 275 Amended NOTICE of Deposition by Merck Sharp & Dohme Corp. (Joyce, Alexandra)
October 28, 2020 Filing 274 NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 27, 2020 Filing 273 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-3) filed by Apotex Corp., Apotex Inc..(Bilson, David)
October 27, 2020 Filing 272 NOTICE OF SERVICE of (1) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.; and (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 27, 2020 Pro Hac Vice Attorneys Steven J. Moore and James E. Nealon for Aurobindo Pharma USA Inc. and Aurobindo Pharma, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01099-RGA, 1:19-md-02902-RGA, 1:20-cv-00949-RGA(kmd)
October 26, 2020 Filing 271 NOTICE OF SERVICE of Defendant DRL's Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6), and Defendant DRL's Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-78) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
October 22, 2020 Filing 270 REDACTED VERSION of #237 Unopposed Motion to Redact Transcript, by Biocon Limited. (Attachments: #1 Proposed Order, #2 Exhibits A-C)(Mowery, Katharine) Modified on 10/22/2020 (nms).
October 22, 2020 Filing 269 REDACTED VERSION of #258 Renewed Motion to Redact Transcript and for a Further Extension of Time to File Redactions, by Biocon Limited. (Attachments: #1 Proposed Order, #2 Exhibits A-C)(Mowery, Katharine) Modified on 10/22/2020 (nms).
October 22, 2020 Filing 267 NOTICE OF SERVICE of (1) Second Set of Interrogaotries from Plaintiff Merck Sharp & Dohme to Defendants and (2) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 22, 2020 Filing 266 REDACTED VERSION of #263 Sealed Transcript. (nms)
October 22, 2020 CORRECTING ENTRY: The redacted filings (D.I. 113 in 19cv311-RGA; D.I. 112 in 19cv312-RGA; D.I. 116 in 19cv313-RGA; D.I. 107 in 19cv314-RGA; D.I. 141 in 19cv317-RGA; D.I. 175 in 19cv318-RGA; D.I. 112 in 19cv319-RGA; D.I. 115 in 19cv347-RGA; D.I. 139 in 19cv1489-RGA; D.I. 268 in 19md2902-RGA; D.I. 41 in 20cv776) have be all been removed as they were incorrectly linked to the sealed filings they related to. Associated Cases: 1:20-cv-00776-RGA et al.(nms)
October 21, 2020 Filing 265 NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
October 21, 2020 Filing 264 NOTICE OF SERVICE of 1) Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Interrogatories to Plaintiff (Nos. 1-5) and 2) Defendant Sun Pharmaceutical Industries Ltd.'s First Set of Requests for Admission to Plaintiff (Nos. 1-9) filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
October 21, 2020 Filing 263 [SEALED] Official Transcript of Discovery Dispute Videoconference held on 9/10/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov.. (Triozzi, Heather) Modified on 10/21/2020 (nms).
October 21, 2020 Opinion or Order Filing 262 ORDER Granting (258 in 19-md-2902-RGA) Unopposed Motion to Redact Transcript and for a Further Extension of Time to to File Redactions. Signed by Judge Richard G. Andrews on 10/21/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
October 21, 2020 Opinion or Order Filing 261 MEMORANDUM ORDER regarding unopposed motion to redact portions of the transcript of a discovery dispute conference. A separate order granting the motion will be filed. Signed by Judge Richard G. Andrews on 10/21/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
October 20, 2020 Filing 260 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
October 19, 2020 Filing 259 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) Regarding the 072 Patent filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
October 16, 2020 Filing 258 [SEALED] MOTION to Redact Transcript and for a Further Extension of Time to to File Redactions - filed by Biocon Limited. (Attachments: #1 Exhibits A-B, #2 Exhibit C, #3 Proposed Order)(Fineman, Steven) Modified on 10/19/2020 (nms).
October 16, 2020 Filing 257 STIPULATION TO EXTEND TIME Plaintiffs' Deadline to Serve Supplemental Infringement Contentions to November 20, 2020 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel)
October 16, 2020 Filing 256 STIPULATION TO EXTEND TIME Plaintiffs' Deadline to Serve Supplemental Infringement Contentions to October 28, 2020 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel)
October 16, 2020 Filing 255 NOTICE OF SERVICE of Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Second Set of Requests for the Production of Documents and Things (No. 4) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
October 16, 2020 Filing 254 NOTICE OF SERVICE of Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Second Set of Interrogatories (Nos. 3-4) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
October 16, 2020 Filing 253 NOTICE OF SERVICE of (1) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. Regarding U.S. Patent No. 7,326,708; (2) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,612,072; (3) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. Regarding U.S. Patent 8,414,921; and (4) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
October 16, 2020 Opinion or Order SO ORDERED, re (256 in 19-md-2902-RGA; 105 in 19-cv-311-RGA) STIPULATION TO EXTEND TIME Plaintiffs' Deadline to Serve Supplemental Infringement Contentions to October 28, 2020. Signed by Judge Richard G. Andrews on 10/16/2020. Associated Cases: 1:19-cv-00311-RGA, 1:19-md-02902-RGA(nms)
October 16, 2020 Opinion or Order SO ORDERED, re (257 in 19-md-2902-RGA; 108 in 19-cv-313-RGA; 26 in 20-cv-749-RGA) STIPULATION TO EXTEND Plaintiffs' Deadline to Serve Supplemental Infringement Contentions to November 20, 2020. Signed by Judge Richard G. Andrews on 10/16/2020. Associated Cases: 1:19-cv-00313-RGA, 1:19-md-02902-RGA, 1:20-cv-00749-RGA(nms)
October 15, 2020 Filing 252 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Responses and Objections to Plaintiff Merck Sharp & Dohme Corp.'s Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
October 15, 2020 Opinion or Order SO ORDERED, re (165 in 19-cv-318-RGA: 129 in 19-cv-1489-RGA; 103 in 19-cv-319-RGA; 99 in 19-cv-314-RGA; 107 in 19-cv-313-RGA; 251 in 19-md-2902-RGA; 107 in 19-cv-347-RGA; 131 in 19-cv-317-RGA; 104 in 19-cv-312-RGA; 102 in 19-cv-311-RGA) STIPULATION TO EXTEND TIME to Serve Supplemental Invalidity and Infringement Contentions to October 21, 2020. Signed by Judge Richard G. Andrews on 10/15/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
October 14, 2020 Filing 251 STIPULATION TO EXTEND TIME to Serve Supplemental Invalidity and Infringement Contentions to October 21, 2020 - filed by Sun Pharmaceutical Industries Ltd.. (Gaza, Anne)
October 13, 2020 Opinion or Order SO ORDERED, re (250 in 19-md-2902-RGA; 106 in 19-cv-347-RGA; 106 in 19-cv-313-RGA; 102 in 19-cv-319-RGA, 101 in 19-cv-311-RGA; 164 in 19-cv-318-RGA; 130 in 19-cv-317-RGA; 128 in 19-cv-1489-RGA; 98 in 19-cv-314-RGA; 103 in 19-cv-312-RGA) Unopposed Motion for Extension of Time to File Redactions. Signed by Judge Richard G. Andrews on 10/13/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
October 9, 2020 Filing 250 Unopposed Motion for Extension of Time to File Redactions - filed by Biocon Limited. (Attachments: #1 Proposed Order)(Mowery, Katharine) Modified on 10/13/2020 (nms).
October 9, 2020 Filing 249 NOTICE to Take Deposition of Plaintiff Merck Sharp & Dohme Corp. on mutually agreed upon date filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) Modified on 10/13/2020 (nms). Modified on 10/13/2020 (nms).
October 9, 2020 Filing 248 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Third Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 9, 2020 Filing 247 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 8, 2020 Filing 246 MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon - filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Ormerod, Eve)
October 8, 2020 Opinion or Order SO ORDERED, re (21 in 20-cv-949-RGA; 20 in 20-cv-1099-RGA; 246 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and James E. Nealon, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited, Aurobindo Pharma, Ltd., Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 10/8/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
October 6, 2020 Filing 245 Amended NOTICE of Deposition of Nurit Perlman by Merck Sharp & Dohme Corp. (Silver, Daniel)
October 6, 2020 Filing 244 NOTICE to Take Deposition of Nayna Duptardar, Rajiv Mathur, Kankhoba Walavalkar, Daxesh Patel, Vishwanath Kenkare, and Kanaksingh Jadhav on See Notice of Details filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 5, 2020 Filing 243 NOTICE OF SERVICE of Sun's Responses and Objections to Plaintiffs' Notice of Rule 30(b)(6) Deposition filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
October 5, 2020 Filing 242 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 11-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
October 5, 2020 Filing 241 NOTICE to Take Deposition of See Notice for Details filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 5, 2020 Filing 240 NOTICE OF SERVICE of 1) produced their Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard, 2) produced the DMF for the Sitagliptin API used in its ANDA Product pursuant to Paragraph 3(c)(ii) of the Scheduling Order, and 3) disclosed to Plaintiff whether Aurobindo could produce reasonable quantities of unexpired samples of Aurobindos ANDA Products and API. filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
October 2, 2020 Opinion or Order Filing 239 ORAL ORDER: The motion to redact (see C.A. 19-311-RGA D.I. 96 ) is DENIED. The redactions are extensive, and the request to redact is unsupported by any statement under oath. I do not think the motion meets the requirements of Avandia Marketing. Ordered by Judge Richard G. Andrews on 10/2/2020. (nms)
October 2, 2020 Filing 238 NOTICE OF SERVICE of (1) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc. and (2) First Set of Requests For Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Ajanta Pharma Limited And Ajanta Pharma USA Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 2, 2020 Filing 237 [SEALED] MOTION Unopposed Motion to Redact Transcript - filed by Biocon Limited. (Attachments: #1 Text of Proposed Order, #2 Exhibit A-C)(Mowery, Katharine)
October 2, 2020 Pro Hac Vice Attorney Matthew M. Holub for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01489-RGA, 1:19-md-02902-RGA(kmd)
September 30, 2020 Filing 236 Answer to Counterclaims of Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/30/2020 (nms).
September 30, 2020 Filing 235 Answer to Counterclaims of Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/30/2020 (nms).
September 29, 2020 Filing 234 NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendants' Notice of Deposition Under Rule 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
September 28, 2020 Filing 233 NOTICE OF SERVICE of 1) Default Standard Paragraph 3 Initial Disclosures and 2) Rule 26 Initial Disclosures filed by Aurobindo Pharma USA Inc., Aurobindo Pharma, Ltd., Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc..(Ormerod, Eve)
September 28, 2020 Filing 232 NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery; and (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 28, 2020 Opinion or Order Filing 231 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 1/22/2021. Amended Pleadings due by 1/22/2021. Fact Discovery completed by 1/22/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00949-RGA, 1:20-cv-01099-RGA(nms)
September 28, 2020 Filing 230 MOTION for Pro Hac Vice Appearance of Attorney Matthew M Holub - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
September 28, 2020 Opinion or Order SO ORDERED, re (121 in 19-cv-1489-RGA; 230 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Matthew M Holub, filed by Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 9/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms)
September 25, 2020 Filing 229 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/28/2020 (nms).
September 25, 2020 Filing 228 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 25, 2020 Filing 227 NOTICE OF SERVICE of (1) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. and (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 25, 2020 Opinion or Order Filing 226 SO ORDERED Granting (121 in 19-cv-317-RGA; 155 in 19-cv-318-RGA; 225 in 19-md-2902-RGA) Stipulation and Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 9/25/2020. Associated Cases: 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
September 25, 2020 Filing 225 STIPULATION and [Proposed] Order Regarding Claim Construction by Merck Sharp & Dohme Corp.. (Silver, Daniel)
September 23, 2020 Filing 224 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Second Supplement Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 18, 2020 Filing 223 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
September 18, 2020 Filing 222 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. and Watson Laboratories, Inc.s Claim Construction Issue Identification [CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
September 16, 2020 Filing 221 NOTICE of Deposition by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 16, 2020 Filing 220 NOTICE OF SERVICE of Defendants' Notice Regarding Unexpired Samples, and Defendants' Production of Core Technical Documents filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
September 11, 2020 Filing 219 NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents and (2) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 11, 2020 Filing 218 NOTICE OF SERVICE of Defendants' Rule 26(a)(1) Initial Disclosures, and Defendants' Initial Disclosures Under Paragraph 3 of the Delaware Default Standard filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(O'Byrne, Stephanie)
September 11, 2020 Filing 217 REDACTED VERSION of #204 Letter, by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Attachments: #1 Certificate of Service)(Gattuso, Dominick) Modified on 9/11/2020 (nms).
September 11, 2020 CORRECTING ENTRY: D.I. 219 has been removed as it was duplicative of the filing at D.I. #217 . (nms)
September 10, 2020 Opinion or Order Filing 216 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/11/2020. Amended Pleadings due by 12/11/2020. Fact Discovery completed by 12/18/2020. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/10/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00847-RGA(nms)
September 10, 2020 Filing 215 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/10/2020 (nms).
September 10, 2020 Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 9/10/2020. Counsel for Plaintiff: D. Silver. Counsel for Defendants: S. Fineman. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al.(lak)
September 9, 2020 Filing 214 REDACTED VERSION of #197 Letter, by Biocon Limited. (Attachments: #1 Exhibits 1-2, #2 Proposed Order)(Mowery, Katharine) Modified on 9/10/2020 (nms).
September 9, 2020 Filing 213 REDACTED VERSION of #189 Letter, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/10/2020 (nms).
September 9, 2020 Filing 212 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 9, 2020 Filing 211 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 9, 2020 Filing 210 NOTICE to Take Deposition of David Decicco on October 30, 2020 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 9, 2020 Filing 209 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Second Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) [HIGHLY CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
September 9, 2020 CORRECTING ENTRY: The redacted filing at D.I. 210 has been removed from the docket. This filing was duplicative of the redacted document filed at D.I. #207 . (nms)
September 9, 2020 Opinion or Order SO ORDERED re Stipulation and Order to Extend Time for Redactions. Signed by Judge Richard G. Andrews on 9/9/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
September 8, 2020 Filing 208 STIPULATION TO EXTEND TIME for submission of redacted public version of Plaintiff's August 31, 2020 Opening Discovery Letter Brief to September 9, 2020 - filed by Biocon Limited. (Mowery, Katharine)
September 8, 2020 Filing 207 REDACTED VERSION of #193 Declaration, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/9/2020 (nms).
September 8, 2020 Filing 206 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 8, 2020 Filing 205 NOTICE OF SERVICE of Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
September 8, 2020 Pro Hac Vice Attorney Calvin E. Wingfield, Jr. for Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Sandoz Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(kmd)
September 4, 2020 Filing 204 [SEALED] Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding supplemental Myerson Declaration. (Attachments: #1 Certificate of Service)(Gattuso, Dominick) Modified on 9/8/2020 (nms).
September 4, 2020 Filing 203 NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories to Plaintiff (Nos. 11-13) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
September 4, 2020 Filing 202 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 4, 2020 Filing 201 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 4, 2020 Filing 200 NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel)
September 4, 2020 Filing 199 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 3, 2020 Filing 198 MOTION for Pro Hac Vice Appearance of Attorney Calvin E. Wingfield Jr. - filed by Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Sandoz Inc.. (Gattuso, Dominick)
September 3, 2020 Opinion or Order SO ORDERED, re (140 in 19-cv-318-RGA; 86 in 19-cv-312-RGA; 198 in 19-md-2902-RGA; 106 in 19-cv-317-RGA) MOTION for Pro Hac Vice Appearance of Attorney Calvin E. Wingfield Jr., filed by Teva Pharmaceutical Industries, Ltd., Sandoz Inc., Watson Laboratories, Inc.. Signed by Judge Richard G. Andrews on 9/3/2020. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
September 2, 2020 Filing 197 [SEALED] Letter to The Honorable Richard G. Andrews, from Steven J. Fineman, responding to opening discovery letter brief. (Attachments: #1 Exhibits 1-2, #2 Proposed Order)(Fineman, Steven) Modified on 9/3/2020 (nms).
September 2, 2020 Opinion or Order Filing 196 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 12/11/2020. Amended Pleadings due by 12/11/2020. Fact Discovery completed by 12/18/2020. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/2/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00815-RGA(nms)
September 1, 2020 Filing 195 NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; and (2) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 1, 2020 Filing 194 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/2/2020 (nms).
September 1, 2020 Filing 193 [SEALED] Supplemental Declaration of Professor Allan S. Myerson, Ph.D. Regarding Claim Construction, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Certificate of Service)(Silver, Daniel) Modified on 9/2/2020 (nms).
September 1, 2020 Filing 192 Official Transcript of Markman Hearing Videoconference held on 08/18/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/22/2020. Redacted Transcript Deadline set for 10/2/2020. Release of Transcript Restriction set for 11/30/2020. (Triozzi, Heather)
September 1, 2020 Filing 191 NOTICE to Take Deposition of Ivan Lee on November 4, 2020 filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
September 1, 2020 Filing 190 NOTICE OF SERVICE of Defendants' Notice of Deposition of Plaintiff Under Federal Rule of Civil Procedure 30(b)(6) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
August 31, 2020 Filing 189 [SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding Opening Discovery Letter Brief. (Attachments: #1 Text of Proposed Order, #2 Exhibit 1-8, #3 Certificate of Service)(Silver, Daniel)
August 31, 2020 Filing 188 NOTICE OF SERVICE of Defendant Sandoz Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Sandoz Inc..(Gattuso, Dominick)
August 31, 2020 Filing 187 Answer to Counterclaims of Teva Pharmaceuticals USA, Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/31/2020 (nms).
August 31, 2020 Filing 186 Answer to Counterclaims of Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc., by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/31/2020 (nms).
August 28, 2020 Filing 185 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Monica Tijerinac, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms).
August 28, 2020 Filing 184 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Laman Alani, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms).
August 28, 2020 Filing 183 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Soumojeet Ghosh, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms).
August 28, 2020 Filing 182 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Kyle A. Fliszar, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms).
August 27, 2020 Filing 181 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Nelo R. Rivera, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms).
August 27, 2020 Filing 180 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Yongkui Sun, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms).
August 27, 2020 Filing 179 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Thorsten Rosner, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms).
August 27, 2020 Filing 178 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Shane W. Krska, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms).
August 27, 2020 Filing 177 NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Joseph D. Armstrong, III, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms).
August 24, 2020 Filing 176 NOTICE OF SERVICE of Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs Notice of Deposition pursuant to Fed. R. Civ. P. 30(b)(6) [Confidential] filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
August 24, 2020 Filing 175 NOTICE of of Change of State of Incorporation by Sandoz Inc. (Gattuso, Dominick)
August 21, 2020 Filing 174 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Fourth Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 158-161) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
August 20, 2020 Opinion or Order Filing 173 ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 9/10/2020, at 10:00 AM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Court's form Patent Scheduling Order (Revised 12/19/2019). The hearing will be held using Skype for business. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 9/3/2020. Ordered by Judge Richard G. Andrews on 8/20/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 20, 2020 Opinion or Order SO ORDERED, re (172 in 19-md-2902-RGA; 23 in 20-cv-776-RGA) Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 8/20/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-00776-RGA(nms)
August 19, 2020 Filing 172 STIPULATION and Proposed Order to Extend Time, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) Modified on 8/20/2020 (nms).
August 19, 2020 Filing 171 Letter to The Honorable Richard G. Andrews, dated August 19, 2020 from Fred Cottrell, regarding opposition to notice of subsequent development. (Cottrell, Frederick) Modified on 8/19/2020 (nms).
August 18, 2020 CORRECTING ENTRY: The letter filed at D.I. 169 has been removed from the docket as it was incompletely captioned and filed. Reference to the underlying civil actions the filing relates to needs to be included. (nms)
August 18, 2020 Minute Entry for proceedings held before Judge Richard G. Andrews - Markman/Status Conference held on 8/18/2020. Counsel for Plaintiff: D. Silver. Counsel for Defendant's: D. Gattuso, J. Philips, F. Cottrell, A. Gaza, S. Fineman. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al.(lak)
August 17, 2020 Filing 170 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) [CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
August 17, 2020 Opinion or Order Filing 168 SO ORDERED Granting Stipulation and Proposed Order as to Venue for Discovery Dispute Regarding Enforcement of Subpoena to Biocon Limited. Signed by Judge Richard G. Andrews on 8/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 17, 2020 Opinion or Order Filing 167 TENTATIVE MARKMAN ORDER (see Order for details). Signed by Judge Richard G. Andrews on 8/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 14, 2020 Filing 166 STIPULATION and [Proposed] Order as to Venue for Discovery Dispute Regarding Enforcement of Subpoena to Biocon Limited by Merck Sharp & Dohme Corp.. (Silver, Daniel)
August 14, 2020 Filing 165 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
August 14, 2020 Opinion or Order Filing 164 ORAL ORDER: The court directs that at the Markman hearing on August 18 the terms surfactant and sitagliptin be argued first, followed by the disputed terms of the 708 patent. Ordered by Judge Richard G. Andrews on 8/13/2020. (lak) Modified on 8/14/2020 (nms).
August 14, 2020 Filing 163 REDACTED VERSION of #159 Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/14/2020 (nms).
August 13, 2020 Filing 162 NOTICE of Subsequent Developments by Merck Sharp & Dohme Corp. (Silver, Daniel)
August 7, 2020 Filing 161 NOTICE of Change of Address for Winston & Strawn LLP's Washington DC Office by Sun Pharmaceutical Industries Ltd. (Wilson, Samantha)
August 7, 2020 Opinion or Order Filing 160 [SEALED] ORDER Granting (159 in 19-md-2902-RGA; 85 in 19-cv-317-RGA) Sealed Stipulation and Proposed Order Regarding Corrected First Amended Complaint. Signed by Judge Richard G. Andrews on 8/7/2020.This order has been emailed to local counsel. Associated Cases: 1:19-cv-00317-RGA, 1:19-md-02902-RGA(nms)
August 7, 2020 Filing 159 [SEALED] STIPULATION and Proposed Order Regarding Corrected First Amended Complaint, by Merck Sharp & Dohme Corp.. (Attachments: #1 First Amended Complaint, #2 Certificate of Service)(Silver, Daniel) Modified on 8/7/2020 (nms).
August 7, 2020 Remark: The dial-in information for the August 18, 2020 Markman/Status Conference is as follows: 1-202-503-1666 Conference ID: 14483986#. Associated Cases: 1:19-md-02902-RGA et al. (lak)
August 7, 2020 CORRECTING ENTRY: Date corrected to August 18, 2020 in the remark above regarding the dial-in information for the Markman/Status conference. Associated Cases: 1:19-md-02902-RGA et al. (lak)
August 7, 2020 CORRECTING ENTRY: The pdf at D.I. #131 has been replaced with an amended version per D.I. #160 . (nms)
August 6, 2020 Filing 158 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Third Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 118-157) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
August 6, 2020 Filing 157 STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the First Amended Complaint to August 10, 2020 - filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick)
August 6, 2020 Filing 156 STIPULATION TO EXTEND TIME for Teva to move, answer, or otherwise respond to the Second Amended Complaint to August 10, 2020 - filed by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick)
August 6, 2020 Opinion or Order SO ORDERED, re (156 in 19-md-2902-RGA; 111 in 19-cv-318-RGA) STIPULATION and Order to Extend Time to move, answer, or otherwise respond to the Second Amended Complaint to August 10, 2020. Signed by Judge Richard G. Andrews on 8/6/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
August 6, 2020 Opinion or Order SO ORDERED, re (83 in 19-cv-317-RGA; 157 in 19-md-2902-RGA) STIPULATION and Order to Extend Time to move, answer, or otherwise respond to the First Amended Complaint to August 10, 2020. Signed by Judge Richard G. Andrews on 8/6/2020. Associated Cases: 1:19-cv-00317-RGA, 1:19-md-02902-RGA(nms)
August 5, 2020 Filing 155 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,612,072 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
August 3, 2020 Opinion or Order Filing 154 ORAL ORDER: The Markman hearing scheduled for August 18, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 8/7/2020. Ordered by Judge Richard G. Andrews on 8/3/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 3, 2020 Filing 153 NOTICE OF SERVICE of (1) Apotex's Initial Disclosures Pursuant to Fed. R. Civl P. 26(a)(1); and (2) Apotex's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Apotex Corp., Apotex Inc., Apotex Inc..(Bilson, David)
August 3, 2020 Filing 152 NOTICE OF SERVICE of Apotex's Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Bilson, David)
July 31, 2020 Filing 151 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 30, 2020 Filing 150 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 29, 2020 Filing 149 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 28, 2020 Filing 148 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Privilege Log filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
July 24, 2020 Filing 147 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 23, 2020 Filing 146 REDACTED VERSION of #133 Amended Complaint, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms).
July 23, 2020 Filing 145 REDACTED VERSION of #129 Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms).
July 23, 2020 Filing 144 REDACTED VERSION of #131 Amended Complaint, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms).
July 23, 2020 Filing 143 REDACTED VERSION of #128 Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms).
July 22, 2020 Filing 142 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
July 22, 2020 Filing 141 NOTICE OF SERVICE of Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
July 22, 2020 Filing 140 NOTICE OF SERVICE of Fourth Set of Joint Requests for the Production of Documents and Things (Nos. 158-161) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
July 22, 2020 Filing 139 NOTICE OF SERVICE of Plaintiff's Rule 26 and Paragraph 3 Initial Disclosures Regarding Certain Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 17, 2020 Filing 138 Joint Appendix, Volume 2, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits 25-45)(Silver, Daniel) Modified on 7/20/2020 (nms).
July 17, 2020 Filing 137 Joint Appendix, Volume 1, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits 1-12, #2 Exhibits 13-17, #3 Exhibits 18-24)(Silver, Daniel) Modified on 7/20/2020 (nms).
July 17, 2020 Filing 136 Joint Claim Construction Brief, filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/20/2020 (nms).
July 17, 2020 Filing 135 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708 ;8,414,921 ;7,612,072 . (Silver, Daniel)
July 17, 2020 Filing 134 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708 ;8,414,921 ;7,468,459 ;7,612,072 . (Silver, Daniel)
July 17, 2020 Filing 133 [SEALED] SECOND AMENDED COMPLAINT against Teva Pharmaceuticals USA, Inc.- filed by Merck Sharp & Dohme Corp..(nms)
July 17, 2020 Opinion or Order Filing 132 [SEALED] ORDER Granting (129 in 19-md-2902-RGA; 96 in 19-cv-318-RGA) Stipulation and Proposed Order Regarding First Amended Complaint. Signed by Judge Richard G. Andrews on 7/17/2020.This order has been emailed to local counsel. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00318-RGA(nms)
July 17, 2020 Filing 131 [SEALED] FIRST AMENDED COMPLAINT against Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., and Teva Pharmaceutical Industries Ltd.- filed by Merck Sharp & Dohme Corp..(nms) (Main Document 131 replaced on 8/7/2020) (nms).
July 17, 2020 Opinion or Order Filing 130 [SEALED] ORDER Granting #128 Stipulation and Proposed Order Regarding First Amended Complaint. Signed by Judge Richard G. Andrews on 7/17/2020.This order has been emailed to local counsel. (nms)
July 16, 2020 Filing 129 [SEALED] STIPULATION and Proposed Order Regarding First Amended Complaint, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Certificate of Service)(Silver, Daniel) Modified on 7/17/2020 (nms).
July 16, 2020 Filing 128 [SEALED] STIPULATION and Proposed Order Regarding First Amended Complaint, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Certificate of Service)(Silver, Daniel) Modified on 7/17/2020 (nms).
July 16, 2020 Filing 127 CONSENT JUDGMENT between Merck Sharp & Dohme Corp. and Alvogen Pine Brook, LLC and Alvogen Malta Operations, Ltd.. Signed by Judge Richard G. Andrews on 7/16/2020. (nms)
July 16, 2020 Filing 126 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) to Teva filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
July 16, 2020 Filing 125 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/16/2020 (nms).
July 13, 2020 Filing 124 NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
July 8, 2020 Filing 123 NOTICE of of Subpoenas by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc. (Attachments: #1 Exhibit A - F)(Fineman, Steven)
July 7, 2020 Filing 122 NOTICE OF SERVICE of Defendants Third Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 118-157) filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick)
July 2, 2020 Filing 121 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s First Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-6) [Highly Confidential] filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
June 29, 2020 Opinion or Order Filing 120 SO ORDERED, re (56 in 19-cv-314-RGA; 58 in 19-cv-312-RGA; 62 in 19-cv-310-RGA; 61 in 19-cv-311-RGA; 62 in 19-cv-313-RGA; 119 in 19-md-02902-RGA; 64 in 19-cv-347-RGA; 63 in 19-cv-317-RGA; 58 in 19-cv-319-RGA; 87 in 19-cv-1489-RGA; 89 in 19-cv-318-RGA) Stipulation and Order. Signed by Judge Richard G. Andrews on 6/29/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
June 26, 2020 Filing 119 STIPULATION and Proposed Order, by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) Modified on 6/29/2020 (nms).
June 25, 2020 Filing 118 NOTICE OF SERVICE of Defendants Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.s Second Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
June 8, 2020 Filing 117 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 108-117) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
June 8, 2020 Filing 116 NOTICE OF SERVICE of Merck Sharp & Dohme Corp.'s Reply Markman Brief filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
May 28, 2020 Filing 115 Consent Judgment between Merck Sharp & Dohme Corp. and Wockhardt Bio AG and Wockhardt USA LLC. Signed by Judge Richard G. Andrews on 5/28/2020. (nms)
May 28, 2020 Filing 114 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 5/28/2020 (nms).
May 27, 2020 Filing 113 NOTICE OF SERVICE of (1) Plaintiffs First Supplemental Responses and Objections to Anchens First Set of Requests for Admission (Nos. 1-8); (2) Plaintiffs First Supplemental Responses and Objections to Anchens First Set of Requests for Production of Documents and Things (Nos. 1-3); and (3) Plaintiffs First Supplemental Responses and Objections to Anchens First Set of Interrogatories (Nos. 1-2) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
May 18, 2020 Opinion or Order SO ORDERED, re MOTION for Pro Hac Vice Appearance of Attorney Elise M. Baumgarten, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 5/18/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
May 18, 2020 Pro Hac Vice Attorney Elise M. Baumgarten for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al.(kmd)
May 14, 2020 Filing 112 MOTION for Pro Hac Vice Appearance of Attorney Elise M. Baumgarten - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for Elise M. Baumgarten)(Silver, Daniel)
May 12, 2020 Filing 111 REDACTED VERSION of #106 NOTICE of Service of Subpoena, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 5/12/2020 (nms).
May 11, 2020 CORRECTING ENTRY: The pdf for the Notice of Service filed on May 8, 2020, has been replaced per counsel's request. The filing has been corrected to reflect the "Second Set" of requests were being served, not the "First Set." Associated Cases: 1:19-md-02902-RGA et al.(nms)
May 8, 2020 Filing 110 NOTICE OF SERVICE of Second Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 108-117), filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) (Main Document 57 replaced on 5/11/2020) (nms). Modified on 5/11/2020 (nms).
May 6, 2020 Filing 109 NOTICE OF SERVICE of Plaintiffs Responses and Objections to Tevas First Set of Requests for the Production of Documents and Things (Nos. 1-79) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
May 5, 2020 Filing 108 NOTICE OF SERVICE of Objections and Responses to the Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp., filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) Modified on 5/6/2020 (nms).
May 4, 2020 Filing 107 NOTICE OF SERVICE of Defendants' Claim Construction Brief filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
May 4, 2020 Filing 106 [SEALED] NOTICE of Service of Subpoena by Merck Sharp & Dohme Corp. (Attachments: #1 Certificate of Service)(Silver, Daniel)
April 30, 2020 Opinion or Order Filing 105 SO ORDERED Granting (104 in 19-md-02902-RGA; 80 in 19-cv-318-RGA) Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 4/30/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
April 30, 2020 Filing 104 STIPULATION and [Proposed] Order Regarding Claim Construction by Merck Sharp & Dohme Corp.. (Silver, Daniel)
April 30, 2020 Filing 103 NOTICE OF SERVICE of Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Amended and Supplemental Disclosures filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
April 28, 2020 Filing 102 CONSENT JUDGMENT between Macleods Pharma USA, Inc., Macleods Pharmaceuticals Limited, and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 4/28/2020. (nms)
April 28, 2020 Filing 101 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 4/28/2020 (nms).
April 27, 2020 Filing 100 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Claim Construction Issue Identification filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
April 27, 2020 Filing 99 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
April 24, 2020 Filing 98 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s First Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
April 23, 2020 Filing 97 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Limited, Lupin Limited; Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick)
April 21, 2020 Filing 96 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. 's Initial Invalidity Contentions filed by Teva Pharmaceutical Industries Ltd..(Gattuso, Dominick)
April 8, 2020 Filing 95 STIPULATION and Proposed Order - filed by Teva Pharmaceutical Industries Ltd.. (Gattuso, Dominick) Modified on 4/8/2020 (nms).
April 8, 2020 Opinion or Order SO ORDERED, re (75 in 19-cv-318-RGA; 95 in 19-md-2902-RGA) STIPULATION and Proposed Order. Signed by Judge Richard G. Andrews on 4/8/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
April 6, 2020 Filing 94 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s First Set of Requests for the Production of Documents and Things directed to Plaintiff (Nos. 1-79) filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
April 3, 2020 Filing 93 NOTICE OF SERVICE of Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
April 1, 2020 Filing 92 REDACTED VERSION of #88 Answer to Counterclaim, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 4/1/2020 (nms).
March 30, 2020 Filing 91 NOTICE OF SERVICE of First Supplemental Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
March 27, 2020 Opinion or Order Filing 90 SO ORDERED Granting #89 Consent Judgment. Signed by Judge Richard G. Andrews on 3/27/2020. (nms)
March 26, 2020 Filing 89 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 3/26/2020 (nms).
March 24, 2020 Filing 88 [SEALED] ANSWER to #78 Answer to Amended Complaint, and Counterclaims, by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel) Modified on 3/25/2020 (nms).
March 20, 2020 Filing 87 NOTICE of Service of Plaintiff Merck Sharp & Dohme Corp.'s Opening Markman Brief by Merck Sharp & Dohme Corp. (Silver, Daniel)
March 20, 2020 Filing 86 NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Defendants First Set of Requests for Admission (Nos. 1-8); (2) Plaintiffs Responses and Objections to Defendants First Set of Requests for Production of Documents and Things (Nos. 1-3); and (3) Plaintiffs Responses and Objections to Anchens First Set of Interrogatories (Nos. 1-2) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 19, 2020 Filing 85 ANSWER to #71 Answer to Amended Complaint, and Counterclaims, by Merck Sharp & Dohme Corp..(Silver, Daniel) Modified on 3/19/2020 (nms).
March 17, 2020 Opinion or Order SO ORDERED, re (54 in 19-cv-313-RGA; 50 in 19-cv-312-RGA; 52 in 19-cv-310-RGA; 83 in 19-md-2902-RGA; 47 in 19-cv-321-RGA; 48 in 19-cv-314-RGA; 55 in 19-cv-347-RGA; 78 in 19-cv-1489-RGA; in 19-cv-311-RGA; 55 in 19-cv-317-RGA; 52 in 19-cv-316-RGA; 50 in 19-cv-319-RGA) Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 3/16/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
March 16, 2020 Filing 84 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 16, 2020 Filing 83 STIPULATION and [Proposed] Order to Amend Scheduling Order, by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Limited. (Seaman, John) Modified on 3/16/2020 (nms).
March 12, 2020 Opinion or Order SO ORDERED, re (80 in 19-md-2902-RGA; 66 in 19-cv-318-RGA) Stipulation and Proposed Order Regarding Joint Claim Construction Chart. Signed by Judge Richard G. Andrews on 3/9/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
March 12, 2020 Opinion or Order SO ORDERED, re (79 in 19-md-2902-RGA; 24 in 19-cv-2192-RGA) Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 3/9/2020. Associated Cases: 1:19-cv-02192-RGA, 1:19-md-02902-RGA(nms)
March 10, 2020 Filing 82 REDACTED VERSION of #76 Notice of Service, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 3/12/2020 (nms).
March 10, 2020 Filing 81 REDACTED VERSION of #78 Answer to Amended Complaint, and Counterclaim, by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Certificate of Service)(Gattuso, Dominick) Modified on 3/12/2020 (nms).
March 9, 2020 Filing 80 STIPULATION and [Proposed] Order Regarding Joint Claim Construction Chart by Merck Sharp & Dohme Corp.. (Silver, Daniel)
March 6, 2020 Filing 79 STIPULATION and [Proposed] Order to Amend Scheduling Order by Accord Healthcare, Inc.. (Kirby, April)
March 4, 2020 Filing 78 [SEALED] ANSWER to #60 Amended Complaint and Counterclaims against Merck Sharp & Dohme Corp., by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Certificate of Service)(Gattuso, Dominick) Modified on 3/4/2020 (nms).
March 3, 2020 Filing 77 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
March 3, 2020 Filing 76 [SEALED] NOTICE OF SERVICE of Subpoena filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certificate of Service)(Silver, Daniel)
March 2, 2020 Filing 75 NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. 's Identification of Proposed Claim Terms of U.S. Patents No.8,414,921 for Construction filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
March 2, 2020 CORRECTING ENTRY: The sealed notice filed at D.I. 73 has been removed from the docket. The filing lacked a certificate of service and reference to any underlying action it related to. Counsel shall refile accordingly. (nms)
February 28, 2020 Filing 74 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
February 28, 2020 Filing 72 NOTICE OF SERVICE of Plaintiff's Rule 26 and Paragraph 3 Initial Disclosures regarding the '921 and '459 Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 27, 2020 Filing 71 ANSWER to Amended Complaint, re: #57 Amended Complaint /Defendants' Answer, Affirmative Defenses and Counterclaims to Plaintiff's First Amended Complaint, COUNTERCLAIM against Merck Sharp & Dohme Corp. by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Limited.(Seaman, John)
February 25, 2020 Filing 70 REDACTED VERSION of #60 Amended Complaint, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/26/2020 (nms).
February 25, 2020 Filing 69 REDACTED VERSION of #55 Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/25/2020 (nms).
February 24, 2020 Filing 68 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 8,414,921 filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
February 24, 2020 REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The #55 . (nms)
February 20, 2020 Opinion or Order Filing 67 SO ORDERED Granting (66 in 19-md-2902-RGA; 51 in 19-cv-347-RGA) Stipulation of Dismissal of Lupin Limited's Third and Fourth Counterclaims Without Prejudice. Signed by Judge Richard G. Andrews on 2/20/2020. Associated Cases: 1:19-cv-00347-RGA, 1:19-md-02902-RGA(nms)
February 19, 2020 Filing 66 STIPULATION of Dismissal of Lupin Limited's Third and Fourth Counterclaims without Prejudice, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) Modified on 2/20/2020 (nms).
February 19, 2020 Filing 65 NOTICE OF SERVICE of 1) First Set of Interrogatories (Nos. 1-2); 2) First Set of Request for Production of Documents and Things (Nos. 1-3); and 3) First Set of Requests for Admission (Nos. 1-8) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
February 19, 2020 Filing 64 CONSENT JUDGMENT between Merck Sharp & Dohme Corp., Torrent Pharma Inc., and Torrent Pharmaceuticals Limited. Signed by Judge Richard G. Andrews on 2/19/2020. Associated Cases: 1:19-cv-00872-RGA, 1:19-md-02902-RGA(nms)
February 19, 2020 Filing 63 CONSENT JUDGMENT between Merck Sharp & Dohme Corp., Torrent Pharma Inc., and Torrent Pharmaceuticals Limited. Signed by Judge Richard G. Andrews on 2/19/2020. Associated Cases: 1:19-cv-00320-RGA, 1:19-md-02902-RGA(nms)
February 18, 2020 Filing 62 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/19/2020 (nms).
February 18, 2020 Filing 61 PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/19/2020 (nms).
February 18, 2020 Filing 60 [SEALED] FIRST AMENDED COMPLAINT against Teva Pharmaceuticals USA, Inc.- filed by Merck Sharp & Dohme Corp..(nms)
February 18, 2020 Opinion or Order Filing 59 [SEALED] ORDER Granting (D.I. 55 in 19-md-2902-RGA; 53 in 19-cv-318-RGA) Sealed Stipulation and Proposed Order Regarding First Amended Complaint. Signed by Judge Richard G. Andrews on 2/18/2020.This order has been emailed to local counsel. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00318-RGA(nms)
February 14, 2020 Filing 58 Joint Claim Construction Chart, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-J)(Silver, Daniel) Modified on 2/18/2020 (nms).
February 14, 2020 Filing 57 FIRST AMENDED COMPLAINT against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Limited- filed by Merck Sharp & Dohme Corp..(nms)
February 14, 2020 Opinion or Order Filing 56 SO ORDERED Granting (45 in 19-cv-316-RGA; 54 in 19-md-2902-RGA) Stipulation and Order Regarding Plaintiff Merck Sharp & Dohme Corp.'s First Amended Complaint. Signed by Judge Richard G. Andrews on 2/14/2020. Associated Cases: 1:19-cv-00316-RGA, 1:19-md-02902-RGA(nms)
February 14, 2020 Filing 55 [SEALED] STIPULATION and [Proposed] Order Regarding Plaintiff Merck Sharp & Dohme Corp.'s First Amended Complaint by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Silver, Daniel)
February 13, 2020 Filing 54 STIPULATION and [Proposed] Order Regarding Plaintiff Merck Sharp & Dohme Corp.'s First Amended Complaint by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Silver, Daniel)
February 11, 2020 Pro Hac Vice Attorney Sarah J Fischer for Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
February 10, 2020 Filing 53 MOTION for Pro Hac Vice Appearance of Attorney Shaobo Zhu and Sarah J. Fischer - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd.. (Gattuso, Dominick)
February 10, 2020 Opinion or Order SO ORDERED, re (52 in 19-cv-318-RGA; 53 in 19-md-2902-RGA; 51 in 19-cv-317-RGA; 46 in 19-cv-312-RGA) MOTION for Pro Hac Vice Appearance of Attorney Shaobo Zhu and Sarah J. Fischer, filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals Industries, Ltd., Sandoz Inc., Watson Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 2/10/2020. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms)
February 10, 2020 Pro Hac Vice Attorney Shaobo Zhu for Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
February 7, 2020 Opinion or Order SO ORDERED, re (D.I. 20 in 19-cv-2192-RGA; D.I. 52 in 19-md-2902-RGA) Stipulation and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 2/7/2020. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-02192-RGA(nms)
February 6, 2020 Filing 52 STIPULATION and [Proposed] Order to Amend Scheduling Order by Accord Healthcare, Inc.. (Seaman, John)
February 3, 2020 Filing 51 NOTICE OF SERVICE of (i) Defendant Accord Healthcare, Inc.'s Rule 26(a)(1) Initial Disclosures; and (ii) Defendant Accord Healthcare, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Accord Healthcare, Inc..(Seaman, John)
January 31, 2020 Filing 50 NOTICE OF SERVICE of Supplemental Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
January 31, 2020 Filing 49 NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
January 30, 2020 Filing 48 STIPULATION and Proposed Order to Amend Scheduling Order - filed by Teva Pharmaceutical Industries Ltd., Sandoz Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) Modified on 1/30/2020 (nms).
January 30, 2020 Opinion or Order SO ORDERED, re (44 in 19-cv-311-RGA; 51 in 19-cv-318-RGA; 45 in 19-cv-312-RGA, 43 in 19-cv-320-RGA; 44 in 19-cv-314-RGA; 44 in 19-cv-316-RGA: 50 in 19-cv-317-RGA, 50 in 19-cv-313-RGA; 46 in 19-cv-319-RGA; 47 in 19-cv-872-RGA; 43 in 19-cv-321-RGA, 48 in 19-md-2902-RGA; 48 in 19-cv-347-RGA; 74 in 19-cv-1489-RGA; 48 in 19-cv-310-RGA) STIPULATION and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 1/30/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
January 24, 2020 Filing 47 NOTICE OF SERVICE of Defendants' Claim Terms for Construction and Proposed Constructions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
January 24, 2020 Filing 46 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
November 18, 2019 Opinion or Order Filing 45 ORAL ORDER re (42 in 1:19-md-02902-RGA) Order Setting Teleconference: The Telephone Conference with Judge Thynge scheduled for 11/18/2019 at 4:00 PM Eastern Time is cancelled. Ordered by Judge Mary Pat Thynge on 11/18/19. Associated Cases: 1:19-cv-00872-RGA, 1:19-md-02902-RGA(cak)
November 14, 2019 Filing 44 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 25, 2019 Filing 43 NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
October 24, 2019 Opinion or Order Filing 42 ORAL ORDER Setting Teleconference: A Telephone Conference is set for 11/18/2019 at 4:00 PM Eastern Time with Judge Mary Pat Thynge. Counsel for Merck shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 10/24/19. Associated Cases: 1:19-cv-00872-RGA, 1:19-md-02902-RGA(cak)
October 21, 2019 Filing 41 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.s First Set of Individual Interrogatories (Nos. 1-2) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 17, 2019 Filing 40 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
October 16, 2019 Filing 39 NOTICE OF SERVICE of 1) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Requests for Production and 2) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Interrogatories filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha)
October 10, 2019 Opinion or Order SO ORDERED, re (68 in 19-cv-1489-RGA, 38 in 19-md-2902-RGA) STIPULATION TO EXTEND TIME for Mylan to serve initial invalidity contentions to October 25, 2019. Signed by Judge Richard G. Andrews on 10/9/2019. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms)
October 9, 2019 Filing 38 STIPULATION TO EXTEND TIME for Mylan to serve initial invalidity contentions to October 25, 2019 - filed by Mylan Pharmaceuticals Inc.. (Dorsney, Kenneth)
October 1, 2019 Filing 37 NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
October 1, 2019 Filing 36 NOTICE OF SERVICE of (1) Defendants Alvogen Pine Brook LLC and Alvogen Malta Operations Ltd.s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) and (2) Defendants Alvogen Pine Brook LLC and Alvogen Malta Operations Ltd.s Objections and Responses to Plaintiffs First Set of Requests for Production (Nos. 1-78) filed by Alvogen Malta Operations Ltd., Alvogen Pine Brook LLC.(Farnan, Kelly)
September 30, 2019 Filing 35 NOTICE OF SERVICE of Defendant Sandoz Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) and Sandoz Inc.'s Objections and Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-78) filed by In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation, Sandoz Inc..(Gattuso, Dominick)
September 30, 2019 Filing 34 NOTICE OF SERVICE of Defendants Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6), and Objections and Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-84) filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation.(Gattuso, Dominick)
September 30, 2019 Filing 33 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) and Objections and Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-78) filed by In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation, Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick)
September 30, 2019 Filing 32 NOTICE OF SERVICE of Defendants Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Responses and Objections to Plaintiff's First Set of Requests for Production (Nos. 1-78) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
September 30, 2019 Filing 31 NOTICE OF SERVICE of Responses and Objections to First Set of Interrogatories (Nos. 1-6) and Responses and Objections to First Set of Requests for Production (Nos. 1-78) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Mosley, Renee)
September 30, 2019 Filing 30 NOTICE OF SERVICE of Defendants Anchen Pharmaceuticals, Inc. and Par Pharmaceutical, Inc.'s Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-6) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
September 30, 2019 Filing 29 NOTICE OF SERVICE of (1) responses to first set of interrogatories and (2) responses to first set of requests for production filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
September 30, 2019 Filing 28 NOTICE OF SERVICE of (1) Defendants Apotex Inc. and Apotex Corp.'s Objections and Responses to Plaintiff's First Set of Interrogatories; and (2) Defendants Apotex Inc. and Apotex Corp.'s Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents filed by Apotex Corp., Apotex Inc..(Bilson, David)
September 23, 2019 Filing 27 NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-10) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine)
September 23, 2019 Filing 26 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra)
September 16, 2019 Opinion or Order Filing 25 ORAL ORDER Setting Teleconference: A Telephone Conference is set for 10/24/2019 at 9:00 AM Eastern Time with Judge Mary Pat Thynge, plaintiff Merck and defendant Torrent entities ONLY. Counsel for the Torrent entities shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 9/16/19. Associated Cases: 1:19-cv-00872-RGA, 1:19-md-02902-RGA(cak)
September 13, 2019 Opinion or Order Filing 24 SO ORDERED Granting (22 in 19-md-2902-RGA; 35 in 19-cv-319-RGA) Stipulation and Proposed Order (*Sun Pharma Global FZE terminated). Signed by Judge Richard G. Andrews on 9/13/2019. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms)
September 13, 2019 Filing 23 NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
September 13, 2019 Filing 22 STIPULATION and [Proposed] Order by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha)
September 10, 2019 Opinion or Order Filing 21 ORAL ORDER re (33 in 1:19-cv-00872-RGA, 20 in 1:19-md-02902-RGA) Order Setting Teleconference: The teleconference scheduled for 9/16/19 at 12:00 Noon with Judge Thynge to discuss ADR is between plaintiff and defendants Torrent ONLY. Ordered by Judge Mary Pat Thynge on 9/10/19. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00872-RGA(cak)
September 6, 2019 Opinion or Order Filing 20 ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 9/16/2019 at 12:00 Noon Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 9/6/19. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00872-RGA(cak)
August 30, 2019 Filing 19 NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s First Sets of Interrogatories and First Sets of Requests for Production to Defendants filed by Merck Sharp & Dohme Corp..(Silver, Daniel)
August 28, 2019 Opinion or Order SO ORDERED, re (32 in 19-cv-316-RGA, 18 in 19-md-2902-RGA, 40 in 19-cv-318-RGA, 39 in 19-cv-313-RGA, 32 in 19-cv-320-RGA, 33 in 19-cv-319-RGA, 33 in 19-cv-314-RGA, 32 in 19-cv-321-RGA, 35 in 19-cv-347-RGA, 32 in 19-cv-311-RGA, 37 in 19-cv-310-RGA, 34 in 19-cv-312-RGA, 39 in 19-cv-317-RGA, 29 in 19-cv-872-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 8/28/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 27, 2019 Filing 18 STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/27/2019 (nms).
August 26, 2019 Filing 17 Answer to Counterclaims of Torrent Pharmaceuticals Limited and Torrent Pharma, Inc. (see D.I. 18 in C.A. No. 19-872-RGA), by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/26/2019 (nms).
August 23, 2019 Filing 16 NOTICE OF SERVICE of Mylan's Core Technical Documents filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
August 23, 2019 Opinion or Order Filing 15 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/14/2020. Amended Pleadings due by 2/14/2020. Fact Discovery completed by 11/20/2020. Joint Claim Construction Brief due by 7/17/2020. A Markman Hearing is set for 8/18/2020, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/23/2019. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-01489-RGA(nms)
August 22, 2019 Filing 14 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/22/2019 (nms).
August 21, 2019 Opinion or Order Filing 13 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/14/2020. Amended Pleadings due by 2/14/2020. Fact Discovery completed by 11/20/2020. Joint Claim Construction Brief due by 7/17/2020. A Markman Hearing is set for 8/18/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00872-RGA(nms)
August 21, 2019 Opinion or Order Filing 12 SO ORDERED regarding Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 21, 2019 CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-md-02902-RGA, 1:19-cv-00872-RGA(cak)
August 20, 2019 Filing 11 NOTICE OF SERVICE of (1) Mylan's Rule 26(a)(1) Initial Disclosures; and (2) Mylan's Paragraph 3 Disclosures filed by Mylan Pharmaceuticals Inc..(Dorsney, Kenneth)
August 20, 2019 Filing 10 NOTICE Of Service of (1) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; and (2) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery, filed by Merck Sharp & Dohme Corp..(Silver, Daniel) Modified on 8/21/2019 (nms).
August 20, 2019 Opinion or Order SO ORDERED, re (55 in 19-cv-1489-RGA, 32 in 19-cv-347-RGA, 30 in 19-cv-319-RGA, 29 in 19-cv-320-RGA, 29 in 19-cv-321-RGA, 36 in 19-cv-313-RGA, 34 in 19-cv-310-RGA, 8 in 19-md-2902-RGA, 29 in 19-cv-316-RGA, 30 in 19-cv-314-RGA, 37 in 19-cv-318-RGA, 24 in 19-cv-872-RGA, 31 in 19-cv-312-RGA, 29 in 19-cv-311-RGA, 36 in 19-cv-317-RGA) STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019. Signed by Judge Richard G. Andrews on 8/15/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms)
August 19, 2019 Filing 9 PROPOSED Stipulated Protective Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms).
August 15, 2019 Filing 8 STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel)
August 15, 2019 Filing 7 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms).
August 15, 2019 Filing 6 NOTICE of Appearance by Alexandra M. Joyce on behalf of Merck Sharp & Dohme Corp. (Joyce, Alexandra)
August 15, 2019 Filing 5 NOTICE of Appearance by Michael P. Kelly on behalf of Merck Sharp & Dohme Corp. (Kelly, Michael)
August 15, 2019 Filing 4 NOTICE of Appearance by Daniel M. Silver on behalf of Merck Sharp & Dohme Corp. (Silver, Daniel)
August 9, 2019 Filing 3 Letter to USDC/NDWV from Clerk, USDC/DE, dated 8/9/2019, regarding request for case to be transferred to Delaware. (amf)
August 8, 2019 Filing 2 NOTICE TO COUNSEL: MDL No. 1:19-md-2902 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02902-RGA et al.(amf)
August 8, 2019 Filing 1 CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 8/8/2019 - Associated Cases: 1:19-md-02902-RGA et al.(amf)
August 8, 2019 NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02902-RGA et al.(amf)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Merck Sharp & Dohme Corp.
Represented By: Frank X. Duff
Represented By: Stanley E. Fisher
Represented By: Anthony H. Sheh
Represented By: Sandra K. Law
Represented By: Jingyuan Luo
Represented By: Daniel M. Silver
Represented By: Alexander S. Zolan
Represented By: Jessamyn S. Berniker
Represented By: Michael P. Kelly
Represented By: Alexandra M. Joyce
Represented By: James F. Companion
Represented By: Anthony Sheh
Represented By: Shaun P. Mahaffy
Represented By: Bruce R. Genderson
Represented By: Vanessa O. Omoroghomwan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Teva Pharmaceuticals USA, Inc.
Represented By: Aaron M. Nelson
Represented By: Christie Larochelle
Represented By: Keith A. Zullow
Represented By: Julius Jefferson
Represented By: Dominick T. Gattuso
Represented By: Shaobo Zhu
Represented By: Sarah J Fischer
Represented By: Calvin E. Wingfield, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Torrent Pharma Inc.
Represented By: A. Neal Seth
Represented By: Laura R. Braden
Represented By: John M. Seaman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Torrent Pharmaceuticals Limited
Represented By: A. Neal Seth
Represented By: Laura R. Braden
Represented By: John M. Seaman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Zydus Pharmaceuticals (USA) Inc.
Represented By: Michael J. Gaertner
Represented By: John C. Phillips, Jr.
Represented By: David B. Abramowitz
Represented By: Carolyn A. Blessing
Represented By: Christopher J. Cassella
Represented By: David A. Bilson
Represented By: Jonathan B. Turpin
Represented By: Timothy F. Peterson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Sun Pharma Global FZE
Represented By: Jovial Wong
Represented By: Samantha G. Wilson
Represented By: Anne Shea Gaza
Represented By: Zachary B. Cohen
Represented By: Charles B. Klein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Alvogen Pine Brook LLC
Represented By: Brett M. Garrison
Represented By: Kelly E. Farnan
Represented By: Matthew J. Becker
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Wockhardt USA LLC
Represented By: David H. Silverstein
Represented By: Kelly E. Farnan
Represented By: Christopher M. Gallo
Represented By: Aziz Burgy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Par Pharmaceuticals, Inc.
Represented By: David H. Silverstein
Represented By: Steven J. Fineman
Represented By: Christopher M. Gallo
Represented By: Katharine Lester Mowery
Represented By: Aziz Burgy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Clerk of MDL Panel
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Lupin Pharmaceuticals, Inc.
Represented By: Andrea L. Cheek
Represented By: Alexandra M. Ewing
Represented By: Frederick L. Cottrell, III
Represented By: Jonathan E. Bachand
Represented By: William R. Zimmerman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Apotex Corp.
Represented By: Guylaine Hache, Ph.D.
Represented By: John C. Phillips, Jr.
Represented By: David A. Bilson
Represented By: Joseph M. Janusz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Macleods Pharma USA, Inc.
Represented By: A. Neal Seth
Represented By: Laura R. Braden
Represented By: John M. Seaman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Wockhardt Bio AG
Represented By: David H. Silverstein
Represented By: Kelly E. Farnan
Represented By: Christopher M. Gallo
Represented By: Aziz Burgy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Lupin Limited
Represented By: Andrea L. Cheek
Represented By: Alexandra M. Ewing
Represented By: Frederick L. Cottrell, III
Represented By: Jonathan E. Bachand
Represented By: William R. Zimmerman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Watson Laboratories, Inc.
Represented By: Aaron M. Nelson
Represented By: Christie Larochelle
Represented By: Keith A. Zullow
Represented By: Julius Jefferson
Represented By: Dominick T. Gattuso
Represented By: Shaobo Zhu
Represented By: Sarah J Fischer
Represented By: Calvin E. Wingfield, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Alvogen Malta Operations Ltd.
Represented By: Brett M. Garrison
Represented By: Kelly E. Farnan
Represented By: Matthew J. Becker
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Cadila Healthcare Ltd.
Represented By: Michael J. Gaertner
Represented By: John C. Phillips, Jr.
Represented By: David B. Abramowitz
Represented By: Carolyn A. Blessing
Represented By: Christopher J. Cassella
Represented By: David A. Bilson
Represented By: Jonathan B. Turpin
Represented By: Timothy F. Peterson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Anchen Pharmaceuticals, Inc.
Represented By: David H. Silverstein
Represented By: Steven J. Fineman
Represented By: Christopher M. Gallo
Represented By: Katharine Lester Mowery
Represented By: Aziz Burgy
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Sandoz Inc.
Represented By: Aaron M. Nelson
Represented By: Christie Larochelle
Represented By: Keith A. Zullow
Represented By: Julius Jefferson
Represented By: Dominick T. Gattuso
Represented By: Shaobo Zhu
Represented By: Sarah J Fischer
Represented By: Calvin E. Wingfield, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Sun Pharmaceutical Industries Ltd.
Represented By: Jovial Wong
Represented By: Samantha G. Wilson
Represented By: Anne Shea Gaza
Represented By: Zachary B. Cohen
Represented By: Charles B. Klein
Represented By: John R. McNair
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Apotex Inc.
Represented By: Guylaine Hache, Ph.D.
Represented By: John C. Phillips, Jr.
Represented By: David A. Bilson
Represented By: Joseph M. Janusz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Mylan Pharmaceuticals Inc.
Represented By: Alissa M. Pacchioli
Represented By: Lance A Soderstrom
Represented By: Gordon H. Copland
Represented By: William J O'Brien
Represented By: Deepro R. Mukerjee
Represented By: Jitendra Malik
Represented By: Joseph M. Janusz
Represented By: Kenneth Laurence Dorsney
Represented By: Lance A. Soderstrom
Represented By: Matthew M. Holub
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Alvogen Pine Brook, Inc.
Represented By: Kelly E. Farnan
Represented By: Brett M. Garrison
Represented By: Matthew J. Becker
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories, Inc.
Represented By: Kendall K. Gurule
Represented By: Stephanie E. O'Byrne
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories, Ltd.
Represented By: Kendall K. Gurule
Represented By: Stephanie E. O'Byrne
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Aurobindo Pharma Limited
Represented By: Eve H. Ormerod
Represented By: James E. Nealon
Represented By: Julie M. O'Dell
Represented By: Steven J. Moore
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Aurobindo Pharma USA, Inc.
Represented By: Eve H. Ormerod
Represented By: James E. Nealon
Represented By: Julie M. O'Dell
Represented By: Steven J. Moore
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Unichem Laboratories Limited
Represented By: R. Touhey Myer
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Unichem Pharmaceuticals (USA) Inc.
Represented By: R. Touhey Myer
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Zydus Worldwide DMCC
Represented By: John C. Phillips, Jr.
Represented By: David A. Bilson
Represented By: Jonathan B. Turpin
Represented By: Leah M. Brackensick
Represented By: Timothy F. Peterson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Macleods Pharmaceuticals Limited
Represented By: A. Neal Seth
Represented By: Laura R. Braden
Represented By: John M. Seaman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
In re: In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Accord Healthcare, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceutical Industries Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Inventia Healthcare Ltd.
Represented By: Roshan P. Shrestha
Represented By: Stephen R. Auten
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Inventia Healthcare LLC
Represented By: Roshan P. Shrestha
Represented By: Stephen R. Auten
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: ScieGen Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bactolac Pharmaceutical Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Laurus Labs Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Laurus Generics Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: S&B Pharma, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?